index	sentence	label
0	When Vitreoscilla were grown in medium containing 60mM @COMPOUND$ under both normal and limited aeration conditions, the levels of Vitreoscilla @PROTEIN$ (VHb) were decreased by greater than 90%, while the levels of the terminal respiratory oxidase, cytochrome bo, were increased 350% under normal aeration and 7-23% under limited aeration.	1
1	The @PROTEIN$ was purified to homogeneity using ammonium @COMPOUND$ precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
2	The @PROTEIN$ was purified to homogeneity using @COMPOUND$ sulfate precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
3	The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of cholesterol and @COMPOUND$.	1
4	The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of @COMPOUND$ and alpha-tocopherol.	1
5	SR-BI binds @PROTEIN$ (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	0
6	@PROTEIN$ binds high-density lipoproteins (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	1
7	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of @COMPOUND$ and alpha-tocopherol homeostasis in proper cognitive function.	0
8	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of cholesterol and @COMPOUND$ homeostasis in proper cognitive function.	0
9	@PROTEIN$ modified the association between cholesterol and cognitive decline, and the association between the ratio of @COMPOUND$ to cholesterol and cognitive functioning.	1
10	@PROTEIN$ modified the association between @COMPOUND$ and cognitive decline, and the association between the ratio of 27-hydroxycholesterol to cholesterol and cognitive functioning.	1
11	Addition of biphasic @PROTEIN$ aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
12	Addition of biphasic @PROTEIN$ aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
13	Addition of biphasic insulin aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
14	Addition of biphasic insulin aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
15	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of metformin and @COMPOUND$ (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
16	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of @COMPOUND$ and pioglitazone (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
17	Serum @PROTEIN$ levels were increased and plasma levels of @COMPOUND$ and MHPG were decreased according to the recovery from the active phase of the disease.	0
18	Serum @PROTEIN$ levels were increased and plasma levels of HVA and @COMPOUND$ were decreased according to the recovery from the active phase of the disease.	0
19	These results suggest that dysfunctions of catecholaminergic neurons and @PROTEIN$ might exist in Sydenham's chorea, and the decreasing catecholamine activities in response to @COMPOUND$ might be associated with the improvement of the disease.	0
20	Based on these validities we identified alterations in the @PROTEIN$ gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with @COMPOUND$.	1
21	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and @PROTEIN$ (POD) activities, and LPO.	0
22	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and @PROTEIN$ (POD) activities, and LPO.	0
23	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (@PROTEIN$) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
24	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, @PROTEIN$ (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
25	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (@PROTEIN$) and peroxidase (POD) activities, and LPO.	0
26	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (@PROTEIN$) activities, and LPO.	0
27	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (@PROTEIN$) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
28	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (@PROTEIN$) and peroxidase (POD) activities, and LPO.	0
29	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and @PROTEIN$.	0
30	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, @PROTEIN$ (SOD) and peroxidase (POD) activities, and LPO.	0
31	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (@PROTEIN$) activities, and LPO.	0
32	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, @PROTEIN$ (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
33	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and @PROTEIN$.	0
34	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, @PROTEIN$ (SOD) and peroxidase (POD) activities, and LPO.	0
35	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
36	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
37	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
38	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
39	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
40	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
41	In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (APP)/@PROTEIN$ (PS-1) double transgenic mouse model of Alzheimer's disease (AD).	0
42	In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (APP)/presenilin-1 (@PROTEIN$) double transgenic mouse model of Alzheimer's disease (AD).	0
43	In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (@PROTEIN$)/presenilin-1 (PS-1) double transgenic mouse model of Alzheimer's disease (AD).	0
44	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of @PROTEIN$ (an APP C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
45	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of C99 (an @PROTEIN$ C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
46	Furthermore, @COMPOUND$ attenuated anxiety-like behavior, up-regulated cerebral @PROTEIN$ protein, and decreased cerebral nitrotyrosine in the transgenic mice.	1
47	Toxicity and characterization of @PROTEIN$-inhibition induced by @COMPOUND$ in Artemia salina larvae.	1
48	@COMPOUND$-induced depressive-like behavior is mediated by @PROTEIN$ activation in mice.	1
49	We report that peripheral administration of @COMPOUND$ (LPS) activates @PROTEIN$ and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests.	1
50	Administration of L-@COMPOUND$, a metabolite of tryptophan that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1
51	Administration of L-kynurenine, a metabolite of @COMPOUND$ that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1
52	However, we also observed that @COMPOUND$ (1alpha-hydroxylase inhibitor) enhanced 25(OH)D(3)-induced @PROTEIN$ expression in breast cancer cells.	1
53	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
54	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
55	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
56	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
57	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
58	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
59	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
60	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
61	The mood stabilizers @COMPOUND$ and valproate activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
62	The mood stabilizers lithium and @COMPOUND$ activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
63	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0
64	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0
65	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1
66	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1
67	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1
68	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1
69	Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor (@PROTEIN$) agents is significantly increased by concomitant @COMPOUND$ (MTX) in rheumatoid arthritis (RA).	1
70	Neither @PROTEIN$ nor ATP altered production of reactive oxygen intermediates (ROI) or reactive @COMPOUND$ intermediates (RNI) by bovine monocytes.	0
71	Neither @PROTEIN$ nor ATP altered production of reactive @COMPOUND$ intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
72	Neither @PROTEIN$ nor @COMPOUND$ altered production of reactive oxygen intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
73	To compare the changes in body composition and in @PROTEIN$ levels in postmenopausal women receiving hormone therapy (HT) or @COMPOUND$.	1
74	Common 677C--&gt;T mutation of the @PROTEIN$ gene affects follicular @COMPOUND$ synthesis.	1
75	Surprisingly, a deletion of the @PROTEIN$ gene affected not only insoluble @COMPOUND$) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.	1
76	The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0
77	The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0
78	The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0
79	The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0
80	The participation of @PROTEIN$ (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0
81	The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0
82	The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by @COMPOUND$ (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).	0
83	The participation of protein kinase A (PKA), protein kinase C (@PROTEIN$) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM @COMPOUND$, respectively).	0
84	The participation of protein kinase A (PKA), @PROTEIN$ (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM @COMPOUND$, and 3 microM genistein, respectively).	0
85	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig @PROTEIN$ (IL-6) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
86	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig interleukin-6 (@PROTEIN$) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
87	Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of gtfB, a known virulence factor, and yfiV, a putative @PROTEIN$ of cell-surface fatty acid genes.	1
88	Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of @PROTEIN$, a known virulence factor, and yfiV, a putative transcriptional regulator of cell-surface fatty acid genes.	1
89	Depletion of @COMPOUND$ levels was accompanied by the induction of @PROTEIN$ (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.	1
90	@COMPOUND$ and wortmannin inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
91	Chloroquine and @COMPOUND$ inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
92	Moreover, PD98059 and SP600125 inhibited only amino acid deprivation-induced upregulation and @COMPOUND$ inhibited only @PROTEIN$-induced upregulation.	1
93	Moreover, PD98059 and @COMPOUND$ inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
94	Moreover, @COMPOUND$ and SP600125 inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
95	Myeloperoxidase (@PROTEIN$) is an endogenous oxidant enzyme that generates reactive @COMPOUND$ species (ROS).	1
96	Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	0
97	@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	1
98	Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	0
99	@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	1
100	Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (@PROTEIN$)1/2, one of the critical regulators of Cx43.	1
101	Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (ERK)1/2, one of the critical regulators of @PROTEIN$.	1
102	@COMPOUND$ accumulated cells in S phase of the cell cycle and reduced @PROTEIN$ expression.	1
103	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
104	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
105	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
106	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
107	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
108	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
109	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml @PROTEIN$ for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (iNOS), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
110	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml IFN-gamma for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (@PROTEIN$), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
111	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), @PROTEIN$ (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
112	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of @PROTEIN$ interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
113	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (@PROTEIN$) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
114	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and @PROTEIN$ (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
115	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (@PROTEIN$), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
116	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (@PROTEIN$), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
117	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), @PROTEIN$ (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
118	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (@PROTEIN$), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
119	Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with IL-3, @PROTEIN$, or GM-CSF as compared with these growth factors alone has been noted.	0
120	Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with @PROTEIN$, SCF, or GM-CSF as compared with these growth factors alone has been noted.	0
121	Combination of @COMPOUND$ with @PROTEIN$ did not induce significantly higher numbers of GM-CFC in comparison with G-CSF alone.	0
122	Joint action of three drugs, namely of @COMPOUND$+ IL-3+ @PROTEIN$, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
123	Joint action of three drugs, namely of @COMPOUND$+ @PROTEIN$+ GM-CSF, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
124	The non-covalent interaction of @COMPOUND$ (BR) with @PROTEIN$ was investigated by the UV spectrometry, circular dichroism (CD) and isothermal titration calorimetry (ITC).	1
125	Adult bone marrow (BM)-derived @PROTEIN$-producing cells (IPCs) are capable of regulating blood @COMPOUND$ levels in chemically induced hyperglycemic mice.	1
126	Treatment with @COMPOUND$ activated glucose metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	1
127	Treatment with benfotiamine activated @COMPOUND$ metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	0
128	Benfotiamine was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to @COMPOUND$.	1
129	Benfotiamine was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to @COMPOUND$.	0
130	@COMPOUND$ was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	1
131	@COMPOUND$ was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	0
132	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, insulin, and @PROTEIN$.	1
133	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, @PROTEIN$, insulin, and GAPDH.	1
134	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, @PROTEIN$, and GAPDH.	1
135	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of @PROTEIN$, glucokinase, insulin, and GAPDH.	1
136	) and two @COMPOUND$ tensions (5 and 20%) were compared for their ability to sustain blastocyst survival and @PROTEIN$ production from days 8 to 11 post-insemination.	0
137	In conclusion, culturing blastocysts of cattle in a 5% @COMPOUND$ environment with M199 containing serum sustains embryo viability and permits constitutive and inducible @PROTEIN$ production.	1
138	Incubation in 20% @COMPOUND$ increases @PROTEIN$ production.	1
139	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1
140	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1
141	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1
142	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1
143	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1
144	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1
145	Then the review evaluates the involvement of @PROTEIN$ activated by the endogenous agonist @COMPOUND$ in the generation and propagation of epileptiform activity.	1
146	We observed that @COMPOUND$ inhibited the proteasome activities and increased the level and insolubility of different @PROTEIN$ species, including phosphorylated tau.	1
147	Role of serotonin @PROTEIN$ receptors in the antidepressant-like effect and the antinociceptive effect of @COMPOUND$ in mice.	1
148	The present study was undertaken to evaluate the potential role of @PROTEIN$ receptors in the antidepressant-like effect and antinociceptive effect of @COMPOUND$.	0
149	These findings show that @PROTEIN$ receptors play differing roles in modulating the antidepressant-like and antinociceptive effects of @COMPOUND$ in the models investigated.	1
150	In contrast, the antinociceptive effect of @COMPOUND$ is probably potentiated due to the blockade of somatodendritic @PROTEIN$ receptors in the same raphe nuclei, facilitating the descending monoaminergic pain control system.	1
151	Moreover, @PROTEIN$ hydrolysis of baicalin sequentially yielded glucuronic acid and @COMPOUND$ as confirmed by co-TLC with authentic samples.	1
152	Moreover, @PROTEIN$ hydrolysis of @COMPOUND$ sequentially yielded glucuronic acid and baicalein as confirmed by co-TLC with authentic samples.	1
153	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of @PROTEIN$ and paxillin in a dose-dependent manner in a Calu-6 xenograft model.	1
154	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of FAK and @PROTEIN$ in a dose-dependent manner in a Calu-6 xenograft model.	1
155	Since biliverdin and @COMPOUND$ are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
156	Since biliverdin and bilirubin are downstream products of @COMPOUND$ degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	0
157	Since @COMPOUND$ and bilirubin are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
158	@COMPOUND$ methylation as well as histone H3 methylation of lysines 9 and 27 contribute independently to @PROTEIN$ gene silencing in adenocarcinoma cell lines and can be reversed by 5-aza-2'-deoxycytidine.	1
159	CpG methylation as well as histone H3 methylation of lysines 9 and 27 contribute independently to @PROTEIN$ gene silencing in adenocarcinoma cell lines and can be reversed by @COMPOUND$.	1
160	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
161	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
162	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	1
163	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	0
164	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
165	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
166	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
167	Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
168	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
169	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
170	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
171	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
172	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
173	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
174	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
175	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
176	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
177	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
178	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
179	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
180	Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
181	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
182	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
183	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
184	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
185	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
186	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
187	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
188	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
189	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
190	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
191	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
192	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to @COMPOUND$ intoxication.	1
193	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
194	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
195	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to @COMPOUND$ intoxication.	1
196	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
197	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
198	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
199	Treating MCF-7 cells with @COMPOUND$-1642 Qdots, but not unconjugated Qdots alone, downregulated @PROTEIN$ levels and rendered cells refractory to IGF-I stimulation.	1
200	Treating MCF-7 cells with @COMPOUND$-1642 Qdots, but not unconjugated Qdots alone, downregulated IGF1R levels and rendered cells refractory to @PROTEIN$ stimulation.	1
201	Our data suggest that @COMPOUND$-1642 Qdots can be used to detect @PROTEIN$ expression and measure changes in cell surface receptor levels.	1
202	We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in quercetin content relative to @COMPOUND$ in leaf tissues, indicating that sequence-specific mRNA degradation of the @PROTEIN$ gene was induced.	0
203	We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in @COMPOUND$ relative to kaempferol in leaf tissues, indicating that sequence-specific mRNA degradation of the @PROTEIN$ gene was induced.	0
204	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single whey acidic protein (@PROTEIN$) domain at the C-terminus.	0
205	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single @PROTEIN$ (WAP) domain at the C-terminus.	0
206	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0
207	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
208	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (@COMPOUND$, 5050) and a blend of PLGA and PHBV.	0
209	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
210	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (@PROTEIN$) from microsphere scaffolds fabricated by using two different polymers, @COMPOUND$) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
211	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine @PROTEIN$ (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), @COMPOUND$) acid (PLGA, 5050) and a blend of PLGA and PHBV.	0
212	It is suggested that @COMPOUND$ acting through the GABA(A) receptor mechanism on the expression of GnRH gene and @PROTEIN$ gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1
213	It is suggested that @COMPOUND$ acting through the GABA(A) receptor mechanism on the expression of @PROTEIN$ gene and GnRH-R gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1
214	It is suggested that @COMPOUND$ acting through the @PROTEIN$ mechanism on the expression of GnRH gene and GnRH-R gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.	1
215	@COMPOUND$ differentially alter @PROTEIN$ (2alpha) and PGE (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
216	@COMPOUND$ differentially alter PGF (2alpha) and @PROTEIN$ (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
217	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
218	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
219	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
220	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
221	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
222	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
223	To test the hypothesis that increasing @COMPOUND$ levels is associated with improved @PROTEIN$ resistance in patients with polycystic ovary syndrome (PCOS).	1
224	mRNA and protein levels of @PROTEIN$, Fas, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1
225	mRNA and protein levels of TNF-alpha, @PROTEIN$, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1
226	In addition, @COMPOUND$ treatment regulated mitochondria-dependent apoptosis pathways by inducing the up-regulation of caspase-9 and caspase-3 and the down-regulation of @PROTEIN$ in hepa1c1c 7 cells.	1
227	Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating @PROTEIN$ and inhibiting the expression of Bcl-2.	1
228	Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating Fas ligands and inhibiting the expression of @PROTEIN$.	1
229	Furthermore, free radical overproduction and oxidative stress were associated with a significant decrease in hepatic @COMPOUND$ levels in septic mice, and with an excessive NO production attributed to the induction of the inducible isoform of NO synthase (@PROTEIN$).	0
230	In fact, hepatic @COMPOUND$ levels were significantly increased in the group of mice receiving the probiotic, and the increased @PROTEIN$ expression both in the colon and lungs was down-regulated in those mice treated with L. fermentum.	1
231	Furthermore, supplementation of specific inhibitors of @PROTEIN$, C4H and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
232	Furthermore, supplementation of specific inhibitors of PAL, C4H and @PROTEIN$ in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
233	Furthermore, supplementation of specific inhibitors of PAL, @PROTEIN$ and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
234	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, @PROTEIN$-, and OPG-mRNA in the THP-1 human monocytic cell line.	0
235	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of @PROTEIN$-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line.	0
236	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, TNF-alpha-, and @PROTEIN$-mRNA in the THP-1 human monocytic cell line.	0
237	@COMPOUND$-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of @PROTEIN$ D1 and activation of caspase-3.	1
238	The recombinant protein exhibited high @PROTEIN$ activity and could catalyze the conversion of L:-Phe to @COMPOUND$.	0
239	To investigate this relationship, we used actively growing young Sprague-Dawley rats and @COMPOUND$, one of the angiogenesis inhibitor (AI) to reveal the relationship of angiogenesis in the effect of @PROTEIN$.	0
240	Functional polymorphisms in the @PROTEIN$ and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and @COMPOUND$ treatment.	1
241	An alpha-numeric code for representing N-linked @COMPOUND$ structures in secreted @PROTEIN$.	1
242	Towards this end, we propose a fixed-length alpha-numeric code for representing N-linked @COMPOUND$ structures commonly found in secreted @PROTEIN$ from mammalian cell cultures.	1
243	Treatment of A549, which express wild-type @PROTEIN$, and H1299, which are p53-deficient, human lung cancer cells with @COMPOUND$ resulted in inhibition of cell proliferation and an increase in apoptotic cell death ; however, A549 cells were more sensitive to the berberine-induced cytotoxic effects than H1299 cells.	1
244	Exogenous spermidine, arsenic and @COMPOUND$ modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1
245	Exogenous @COMPOUND$, arsenic and beta-aminobutyric acid modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and @PROTEIN$ gene expression in tobacco leaves.	1
246	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and @PROTEIN$ (ADC)).	1
247	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (@PROTEIN$ PR-1a and PR-2 and arginine decarboxylase (ADC)).	1
248	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and arginine decarboxylase (@PROTEIN$)).	1
249	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule @COMPOUND$ and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and @PROTEIN$ and arginine decarboxylase (ADC)).	1
250	However, @COMPOUND$ exhibited more potency in reducing @PROTEIN$ activity than methiocarb.	1
251	However, methomyl exhibited more potency in reducing @PROTEIN$ activity than @COMPOUND$.	1
252	Significant @PROTEIN$ activity changes, sensitivity of isozyme patterns (Mr of 60, 64, and 85kDa) and increased variation in ALP plasticity during acute exposure to @COMPOUND$ point to its possible aplication as an exposure biomarker.	1
253	Overexpression of @PROTEIN$ induces HepG2 cells death by the AMP kinase activator @COMPOUND$ (AICAR).	1
254	@COMPOUND$ induced apoptosis in androgen-dependent PWR-1E cells via a caspase-dependent and @PROTEIN$-independent mechanism.	1
255	In androgen-independent PC-3 cells, @COMPOUND$ also induced apoptosis by mechanisms that were partially inhibited by pan-caspase inhibition but were partially @PROTEIN$ dependent.	1
256	The production of rhG-@PROTEIN$ was induced by switching from growth on @COMPOUND$ to growth on methanol.	0
257	The production of rhG-@PROTEIN$ was induced by switching from growth on glycerol to growth on @COMPOUND$.	1
258	In the induction phase, the @COMPOUND$ feed rate had a significant effect on the specific expression rate of rhG-@PROTEIN$.	1
259	Under this condition, a maximum concentration of 300 mg/l of rhG-@PROTEIN$ and the expression yield of 0.6 mg of rhG-CSF/g of @COMPOUND$ were attained.	1
260	Among seven additives tested, @COMPOUND$, Tween 80 and betaine exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1
261	Among seven additives tested, Tween 20, Tween 80 and @COMPOUND$ exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1
262	Prior to @COMPOUND$ supplementation, exercise induced a significant decrease in @PROTEIN$ activity, EMF, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0
263	Prior to vitamin E supplementation, exercise induced a significant decrease in @PROTEIN$ activity, @COMPOUND$, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0
264	After a 10 week vitamin E supplementation period, these exercise-induced changes in @PROTEIN$ activity, @COMPOUND$ and MDA concentration were still significant in the control group, but not in the supplemented group.	0
265	After a 10 week @COMPOUND$ supplementation period, these exercise-induced changes in @PROTEIN$ activity, EMF and MDA concentration were still significant in the control group, but not in the supplemented group.	1
266	In adulthood, @COMPOUND$ secreted by the testes is converted into estrogens by the preoptic @PROTEIN$.	1
267	Interestingly, @COMPOUND$ inhibited the expression of ICAM and @PROTEIN$, followed by the suppression of macrophage recruitment into the aortic wall at 1 week after operation.	1
268	In addition, synthesis of collagen and @PROTEIN$ in the vascular wall were significantly increased by @COMPOUND$.	1
269	@COMPOUND$ up-regulates and activates @PROTEIN$-zeta in EBV-infected and EBV-transformed human B-cells.	1
270	We have proposed that @COMPOUND$ (CsA), despite being a @PROTEIN$, will activate PKC in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
271	We have proposed that @COMPOUND$ (CsA), despite being a calcineurin inhibitor, will activate @PROTEIN$ in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
272	After @COMPOUND$ stimulation of SV-FHAS and neoplastic astrocytes, real-time polymerase chain reaction showed an increase of the CPE, containing @PROTEIN$ splice variant only in astrocytoma cells.	0
273	Coexpression pattern with @PROTEIN$ provides an indication that @COMPOUND$ could be the modulator of these adaptive responses to involution and dietary P restriction.	1
274	Dietary chia seed (Salvia hispanica L.) rich in @COMPOUND$ improves adiposity and normalises hypertriacylglycerolaemia and @PROTEIN$ resistance in dyslipaemic rats.	1
275	The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in @COMPOUND$ and fibre upon dyslipidaemia and @PROTEIN$ resistance (IR), induced by intake of a sucrose-rich (62.5 %) diet (SRD).	0
276	The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in alpha-linolenic acid and fibre upon dyslipidaemia and @PROTEIN$ resistance (IR), induced by intake of a @COMPOUND$-rich (62.5 %) diet (SRD).	0
277	Phospholipidosis and down-regulation of the @PROTEIN$-K/PDK-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
278	Phospholipidosis and down-regulation of the PI3-K/PDK-1/@PROTEIN$ signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
279	Phospholipidosis and down-regulation of the PI3-K/@PROTEIN$-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
280	@PROTEIN$ antagonism augments @COMPOUND$-induced downregulation of the 5-HT transporter.	1
281	In contrast, chronic @COMPOUND$ markedly decreased 5-@PROTEIN$ levels in all regions.	1
282	This downregulation of 5-@PROTEIN$ by @COMPOUND$ and its enhancement by Org 34850 can explain our recent observation that GR antagonists augment the SSRI-induced increase in extracellular 5-HT.	1
283	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
284	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
285	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
286	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
287	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
288	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
289	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
290	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
291	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
292	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
293	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
294	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
295	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
296	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
297	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
298	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
299	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
300	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
301	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
302	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
303	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
304	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
305	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
306	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
307	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
308	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
309	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
310	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
311	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
312	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
313	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
314	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
315	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
316	Screening of risk factors for thromboembolism revealed that all patients carried a @PROTEIN$ 677C--&gt;T (MTHFR) mutation in a gene involved in folate metabolism, and either borderline or elevated @COMPOUND$ levels.	0
317	Screening of risk factors for thromboembolism revealed that all patients carried a methylenetetrahydrofolate reductase 677C--&gt;T (@PROTEIN$) mutation in a gene involved in folate metabolism, and either borderline or elevated @COMPOUND$ levels.	0
318	@COMPOUND$ could selectively inhibited @PROTEIN$ expression and PGE2 production.	1
319	Celecoxib could selectively inhibited @PROTEIN$ expression and @COMPOUND$ production.	0
320	@COMPOUND$ also inhibited p(473Ser) Akt, raf and p53 expression, and induced apoptosis by release of @PROTEIN$ and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
321	@COMPOUND$ also inhibited p(473Ser) @PROTEIN$, raf and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
322	@COMPOUND$ also inhibited p(473Ser) Akt, @PROTEIN$ and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
323	@COMPOUND$ also inhibited p(473Ser) Akt, raf and @PROTEIN$ expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
324	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or @COMPOUND$.	1
325	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with @COMPOUND$, escitalopram, or venlafaxine.	1
326	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, @COMPOUND$, or venlafaxine.	1
327	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, escitalopram, or @COMPOUND$ and 20 healthy controls.	1
328	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with @COMPOUND$, escitalopram, or venlafaxine and 20 healthy controls.	1
329	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, @COMPOUND$, or venlafaxine and 20 healthy controls.	1
330	@COMPOUND$ increased @PROTEIN$ levels after 5 weeks and 6 months of treatment.	1
331	@COMPOUND$ increased @PROTEIN$ levels only after 6 months.	1
332	@COMPOUND$ did not affect @PROTEIN$ levels at either time point.	0
333	The increase of @COMPOUND$ was accompanied by a marked posttranslational down-regulation of liver @PROTEIN$ expression.	0
334	Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of SR-BI in mouse liver via a mechanism likely involving @PROTEIN$.	0
335	Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of @PROTEIN$ in mouse liver via a mechanism likely involving PDZK1.	1
336	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (AVP) and @PROTEIN$ mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0
337	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (@PROTEIN$) and CRH mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0
338	Here we demonstrate that an AR ligand, @COMPOUND$ (DHT), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
339	Here we demonstrate that an AR ligand, 5-alpha-dihydrotestosterone (@COMPOUND$), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
340	We found that @COMPOUND$ induced the activation of JNK, @PROTEIN$, and p38 MAPKs.	1
341	We found that @COMPOUND$ induced the activation of JNK, ERK, and @PROTEIN$.	1
342	We found that @COMPOUND$ induced the activation of @PROTEIN$, ERK, and p38 MAPKs.	1
343	@COMPOUND$-induced JNK activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic @PROTEIN$ and Bcl-xL proteins.	1
344	@COMPOUND$-induced @PROTEIN$ activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic Bcl-2 and Bcl-xL proteins.	1
345	In comparison, @COMPOUND$-induced activation of @PROTEIN$ and p38 in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.	1
346	In comparison, @COMPOUND$-induced activation of ERK and @PROTEIN$ in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.	1
347	Mechanistically, inhibition of @PROTEIN$ and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
348	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic @PROTEIN$ and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
349	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and @PROTEIN$ cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
350	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and @PROTEIN$, thereby preventing them from degradation during @COMPOUND$ treatment.	0
351	Mechanistically, inhibition of ERK and @PROTEIN$ activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
352	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of @COMPOUND$ (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	0
353	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of @COMPOUND$ (METH).	1
354	Accumulating evidence suggests that @COMPOUND$ (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	1
355	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (PGE (2)) concentrations, accompanied by a compensatory increase in @PROTEIN$ mRNA expression.	1
356	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (@PROTEIN$ (2)) concentrations, accompanied by a compensatory increase in COX-2 mRNA expression.	1
357	However, @COMPOUND$ had no effect on @PROTEIN$ protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible nitric-oxide synthase.	0
358	However, @COMPOUND$ had no effect on COX-2 protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible @PROTEIN$.	0
359	These data indicate that @COMPOUND$ reduces intratesticular activity of @PROTEIN$ (as indicated by PGE (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1
360	These data indicate that @COMPOUND$ reduces intratesticular activity of COX-2 (as indicated by @PROTEIN$ (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1
361	These results indicate significant roles for products of the @PROTEIN$ pathway in testicular vascular control and steroidogenesis, which may have implications for men with marginal fertility taking @COMPOUND$ for extended periods, but also highlight the potential of this drug to ameliorate testicular damage caused by systemic or local inflammation.	1
362	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and IL-4 as well as cell proliferation but suppressed specific IgG2a and @PROTEIN$ levels.	1
363	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and @PROTEIN$ as well as cell proliferation but suppressed specific IgG2a and IFN-gamma levels.	1
364	In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1
365	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on esterases, @PROTEIN$, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
366	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on @PROTEIN$, phenol sulfotransferases, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
367	@COMPOUND$ impairs @PROTEIN$-dependent gene expression in porcine kidney tubulus cells.	1
368	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor @PROTEIN$ as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
369	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including @PROTEIN$ and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
370	@PROTEIN$ was induced by @COMPOUND$, a well-known activator of this transcription factor.	1
371	@COMPOUND$ significantly decreased gamma-glutamylcysteinyl synthetase and @PROTEIN$ mRNA levels in LLC-PK1 cells.	1
372	Furthermore, @COMPOUND$ also lowered @PROTEIN$ mRNA levels.	1
373	Current data indicate that @COMPOUND$ nephrotoxicity may be, at least partly, mediated by an @PROTEIN$-dependent signal transduction pathway.	1
374	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
375	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
376	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
377	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
378	@PROTEIN$-alpha inhibition protects against @COMPOUND$-induced endothelial glycocalyx perturbation.	1
379	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether @PROTEIN$-alpha (TNFalpha) plays a role in this process.	0
380	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether tumor necrosis factor-alpha (@PROTEIN$) plays a role in this process.	0
381	The amino acid sequence deduced from the coding sequence encodes for @PROTEIN$ of 73 amino acids containing 21 @COMPOUND$ residues.	1
382	Ultrastructural analysis in the macaque mediodorsal nucleus revealed that thalamic interneurons are a main postsynaptic target of @PROTEIN$-ir axons ; this suggests that the marked expansion of the @COMPOUND$ innervation in the primate in comparison to the rodent thalamus may be related to the presence of a sizable interneuron population in primates.	0
383	@PROTEIN$-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-actin polymerization with @COMPOUND$ in hippocampal slices.	1
384	Synapsin-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-@PROTEIN$ polymerization with @COMPOUND$ in hippocampal slices.	1
385	To test the hypothesis that @COMPOUND$S production from DHEA occurs in hepatic cells and that this production is augmented by the presence of sex steroids or @PROTEIN$.	0
386	To test the hypothesis that @COMPOUND$ production from DHEA occurs in hepatic cells and that this production is augmented by the presence of sex steroids or @PROTEIN$.	0
387	Changes in @PROTEIN$ (TNF) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
388	Changes in tumor necrosis factor (@PROTEIN$) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
389	Changes in @PROTEIN$ (TNF) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
390	Changes in tumor necrosis factor (@PROTEIN$) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
391	This prospective cross-sectional study was performed to investigate the influence of GH excess on @PROTEIN$ and ghrelin levels at baseline and after @COMPOUND$ load in a large group of acromegalic patients.	0
392	This prospective cross-sectional study was performed to investigate the influence of GH excess on leptin and @PROTEIN$ levels at baseline and after @COMPOUND$ load in a large group of acromegalic patients.	0
393	DNA array studies have revealed that @PROTEIN$ is strongly up-regulated by nitroso-glutathione (@COMPOUND$) and also displays a 12-fold increase in expression during biofilm growth of E. coli 83972 and VR50 in human urine.	1
394	We found that the third @COMPOUND$ in @PROTEIN$, Cys122, is oxidized to a sulfenic acid.	0
395	We found that the third cysteine in @PROTEIN$, Cys122, is oxidized to a @COMPOUND$.	0
396	E. coli thioredoxin reductase and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced @PROTEIN$.	1
397	E. coli @PROTEIN$ and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced YhaK.	0
398	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and @PROTEIN$ while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
399	With supplementation of @COMPOUND$ in diet, lower expression of @PROTEIN$ and VEGF while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
400	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of GLAST, GS and @PROTEIN$ in retina of diabetic rats were determinated by RT-PCR 0.05).	1
401	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of @PROTEIN$, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
402	@PROTEIN$, VEGF, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
403	GFAP, VEGF, @PROTEIN$, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
404	GFAP, VEGF, GLAST, GS and @PROTEIN$ expressions in normal controls were not altered by @COMPOUND$ treatment.	0
405	GFAP, @PROTEIN$, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
406	In conclusion, @COMPOUND$-A has sufficient bonding strength and comparatively low toxicity in clinical use of 0.3 mmol or less of TAD and 0.8 mL of 44 w/w % @PROTEIN$ solution.	0
407	In the present study we explored the possibility of using genetic engineering to increase the @COMPOUND$ content of A. annua by suppressing the expression of @PROTEIN$ (squalene synthase), a key enzyme of sterol pathway (a pathway competitive with that of artemisinin biosynthesis) by means of a hairpin-RNA-mediated RNAi (RNA interference) technique.	0
408	It has been reported that @COMPOUND$ may affect hepatoma cell growth in vitro by suppressing transforming growth factor beta-1 (@PROTEIN$) expression, suggesting that tamoxifen might also retard fibrogenesis.	1
409	Thus, we examined whether @COMPOUND$ might suppress @PROTEIN$ expression and consequently inhibit the process of hepatic fibrosis in vivo.	0
410	We also explored the effect of @PROTEIN$ released by @COMPOUND$ because this neuropeptide is known to affect the microvasculature environment.	0
411	We also explored the effect of substance P released by @COMPOUND$ because this @PROTEIN$ is known to affect the microvasculature environment.	0
412	@COMPOUND$ perfusion marginally increased @PROTEIN$ levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.	1
413	In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both @PROTEIN$ and BDNF.	1
414	In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both NGF and @PROTEIN$.	1
415	@COMPOUND$ induces PON1 expression through p44/42 mitogen-activated @PROTEIN$ signaling cascade in Huh7 cells.	1
416	@COMPOUND$ induces PON1 expression through @PROTEIN$/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
417	@COMPOUND$ induces @PROTEIN$ expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
418	Both @PROTEIN$ gene promoter activity and PON1 protein expression were elevated by @COMPOUND$ stimulation.	1
419	@COMPOUND$ phosphorylated @PROTEIN$/42 MAP kinase.	1
420	@COMPOUND$ increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by PD98059.	1
421	Pitavastatin increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by @COMPOUND$.	1
422	Pitavastatin increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by @COMPOUND$.	1
423	@COMPOUND$ increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by PD98059.	1
424	These observations suggest that @COMPOUND$ phosphorylates @PROTEIN$/42 MAP kinase and then activates the transcription of PON1 gene and increases the PON1 protein expression in Huh7 cells.	1
425	These observations suggest that @COMPOUND$ phosphorylates p44/42 MAP kinase and then activates the transcription of @PROTEIN$ gene and increases the PON1 protein expression in Huh7 cells.	1
426	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to PON1 DNA through the activation of @PROTEIN$/42 MAP kinase signaling cascade.	1
427	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of @PROTEIN$ and the Sp1 binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	0
428	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the @PROTEIN$ binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	1
429	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to @PROTEIN$ DNA through the activation of p44/42 MAP kinase signaling cascade.	1
430	Inhibition of cyclooxygenase 2 expression by @COMPOUND$ on joint inflammation induced by urate crystal and @PROTEIN$.	0
431	Inhibition of @PROTEIN$ expression by @COMPOUND$ on joint inflammation induced by urate crystal and IL-1beta.	1
432	Investigation of the effects of @COMPOUND$ (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by monosodium urate (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
433	Investigation of the effects of diallyl sulfide (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by @COMPOUND$ (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
434	BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of @COMPOUND$ and prednisone compared with mitoxantrone and prednisone.	0
435	BMI and @COMPOUND$ levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and prednisone compared with mitoxantrone and prednisone.	0
436	BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and prednisone compared with @COMPOUND$ and prednisone.	0
437	BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and @COMPOUND$ compared with mitoxantrone and prednisone.	0
438	In multivariate analysis, neither BMI, presence of obesity, nor baseline @COMPOUND$ was significantly associated with OS or @PROTEIN$ declines.	0
439	The interaction between PAF and the platelet agonists ADP, @PROTEIN$ and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (MRS-2179), and P2Y12 (@COMPOUND$) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).	0
440	The interaction between PAF and the platelet agonists ADP, @PROTEIN$ and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (@COMPOUND$), and P2Y12 (cangrelor) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).	0
441	@PROTEIN$ have the unique ability to catalyze oxidative cleavage of C-C bonds and @COMPOUND$ (C-O-C) bonds in non-phenolic aromatic substrates of high redox potential.	1
442	Manganese @PROTEIN$ oxidize Mn(II) to @COMPOUND$), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
443	Manganese @PROTEIN$ oxidize @COMPOUND$) to Mn(III), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
444	@PROTEIN$ are multi-@COMPOUND$-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular oxygen to water.	1
445	@PROTEIN$ are multi-copper-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular @COMPOUND$ to water.	1
446	@PROTEIN$ catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate @COMPOUND$ residues and modifies the extracellular matrix.	1
447	We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0
448	We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0
449	We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0
450	We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0
451	Dietary deficiency induced marked elevation of hepatic serine and @COMPOUND$ levels associated with enhancement of @PROTEIN$ mRNA expression and repression of SDS mRNA expression.	0
452	Dietary deficiency induced marked elevation of hepatic @COMPOUND$ and threonine levels associated with enhancement of @PROTEIN$ mRNA expression and repression of SDS mRNA expression.	0
453	Dietary deficiency induced marked elevation of hepatic serine and @COMPOUND$ levels associated with enhancement of PHGDH mRNA expression and repression of @PROTEIN$ mRNA expression.	0
454	Dietary deficiency induced marked elevation of hepatic @COMPOUND$ and threonine levels associated with enhancement of PHGDH mRNA expression and repression of @PROTEIN$ mRNA expression.	0
455	In conclusion, our results indicate that chronic @COMPOUND$ modulates the expression and subcellular localization of proteins implicated in @PROTEIN$ signaling, calcium-buffering potential, and trafficking.	1
456	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor @COMPOUND$ (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	0
457	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (@COMPOUND$).	0
458	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), @COMPOUND$ (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	1
459	Di-@COMPOUND$ phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (@PROTEIN$) enzymatic and biological activities: in vitro and in vivo studies.	1
460	@COMPOUND$, a synthetic triterpenoid, inhibits expression of IL-6 and @PROTEIN$ phosphorylation in multi-drug resistant ovarian cancer cells.	1
461	@COMPOUND$, a synthetic triterpenoid, inhibits expression of @PROTEIN$ and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.	1
462	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
463	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
464	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
465	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
466	These studies demonstrated that @COMPOUND$ significantly inhibits IL-6 secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced @PROTEIN$ nuclear translocation.	1
467	These studies demonstrated that @COMPOUND$ significantly inhibits @PROTEIN$ secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced Stat3 nuclear translocation.	1
468	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, @PROTEIN$, and Src phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
469	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, Jak2, and @PROTEIN$ phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
470	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-@PROTEIN$ and Src signaling pathways.	1
471	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-Stat3 and @PROTEIN$ signaling pathways.	1
472	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the @PROTEIN$-Stat3 and Src signaling pathways.	1
473	@COMPOUND$ regulates expressions of VEGF and @PROTEIN$ stimulated by STZ.	1
474	@COMPOUND$ regulates expressions of @PROTEIN$ and HIF-1alpha stimulated by STZ.	1
475	In patients with hypertension and diabetes, @COMPOUND$, ACEi and diuretic treatment increased @PROTEIN$ activation only during the first week.	1
476	Although the co-expression of @PROTEIN$ and CMP-SAS did not further increase sialylation, an increase in the intracellular pool of CMP-@COMPOUND$ was noted.	1
477	NOPE-@COMPOUND$ treatment improved @PROTEIN$ 0.0001).	1
478	11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive cortisone to active @COMPOUND$.	1
479	11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive @COMPOUND$ to active cortisol.	1
480	Vesicle mobilization requires @COMPOUND$+)-induced Ca2+ release by presynaptic endoplasmic reticulum (ER) ryanodine receptors (@PROTEIN$) that in turn stimulates Ca2+/calmodulin-dependent kinase II (CamKII).	1
481	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (@COMPOUND$) and tyrosine kinase inhibitors (herbimycin A and tyrphostin 46).	1
482	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (@COMPOUND$ and tyrphostin 46).	1
483	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (herbimycin A and @COMPOUND$).	1
484	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via RhoA activation and @PROTEIN$ phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
485	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via @PROTEIN$ activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
486	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and @PROTEIN$ reorganization via RhoA activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	0
487	There was no correlation between the presence of significant heart-valve regurgitation and @COMPOUND$ cumulative dose, duration of cabergoline treatment, prior use of bromocriptine, age, adenoma size, or @PROTEIN$ levels.	0
488	There was no correlation between the presence of significant heart-valve regurgitation and cabergoline cumulative dose, duration of cabergoline treatment, prior use of @COMPOUND$, age, adenoma size, or @PROTEIN$ levels.	0
489	@COMPOUND$ phosphorylated p38 and @PROTEIN$ kinases, and blocking of these kinases with specific inhibitors diminished the palmitate-induced cytokine secretion.	0
490	Palmitate phosphorylated @PROTEIN$ and JNK kinases, and blocking of these kinases with specific inhibitors diminished the @COMPOUND$-induced cytokine secretion.	0
491	@COMPOUND$ phosphorylated @PROTEIN$ and JNK kinases, and blocking of these kinases with specific inhibitors diminished the palmitate-induced cytokine secretion.	1
492	Palmitate phosphorylated p38 and @PROTEIN$ kinases, and blocking of these kinases with specific inhibitors diminished the @COMPOUND$-induced cytokine secretion.	1
493	@COMPOUND$ also activated the @PROTEIN$ (c-Jun) transcription factor.	1
494	Optimization of decolorization of @COMPOUND$ (MB) dye by @PROTEIN$ (LiP) enzyme produced by white-rot fungus Phanerochaete chrysosporium using sewage treatment plant (STP) sludge as a major substrate was carried out in the laboratory.	1
495	ATP-gated @PROTEIN$ receptors on excitatory nerve terminals onto interneurons initiate a form of asynchronous @COMPOUND$ release.	1
496	However asynchronous EPSCs were increased following synaptic depression and a component of these appeared to be initiated by endogenously released @COMPOUND$ acting on presynaptic @PROTEIN$ receptors.	1
497	Unexpectedly, the data suggest @PROTEIN$ receptor activation initiates a form of asynchronous @COMPOUND$ release, rather than detectably affecting the vesicles underlying action potential evoked release.	1
498	The second enzyme of @COMPOUND$ synthesis, GSH synthase (GS) is also regulated in a coordinated manner as @PROTEIN$ subunits and its up-regulation can further enhance the capacity of the cell to synthesize GSH.	1
499	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced insulin secretion, effects that are mediated mainly through the @PROTEIN$ receptor.	1
500	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced @PROTEIN$ secretion, effects that are mediated mainly through the prolactin receptor.	1
501	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is @PROTEIN$-dependent and is associated with enhanced insulin secretion.	1
502	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is JAK2-dependent and is associated with enhanced @PROTEIN$ secretion.	1
503	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of @PROTEIN$ is JAK2-dependent and is associated with enhanced insulin secretion.	1
504	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is @PROTEIN$-independent and is dissociated from insulin secretion.	1
505	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from @PROTEIN$ secretion.	0
506	In contrast, @PROTEIN$-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from insulin secretion.	1
507	Plasma levels of @COMPOUND$, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum ferritin and @PROTEIN$ saturation.	1
508	Plasma levels of @COMPOUND$, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum @PROTEIN$ and transferrin saturation.	1
509	The structure-activity relationship between @COMPOUND$ derivatives showing inhibitory effects on @PROTEIN$ in mouse macrophage RAW264.7 cells.	1
510	We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by lipopolysaccharide.	0
511	We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by @COMPOUND$.	1
512	We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by @COMPOUND$.	1
513	We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by lipopolysaccharide.	0
514	Inhibition of protein synthesis by @COMPOUND$ reduces @PROTEIN$ expression in normoxic and hypoxic pancreatic cancer cells.	1
515	Western blot analyses of @COMPOUND$-treated cells demonstrated that imexon reduces @PROTEIN$ protein levels in both normoxic and hypoxic conditions in a time- and concentration-dependant fashion.	1
516	@COMPOUND$ did not similarly affect @PROTEIN$ levels.	0
517	Concurrently, the half-life of existing @PROTEIN$ protein was increased by @COMPOUND$, in association with a marked inhibition of chymotryptic activity in the 20S proteasome.	1
518	The inhibition of @PROTEIN$ translation was not specific, rather it was part of a general decrease in protein translation caused by @COMPOUND$.	1
519	To determine whether a regimen of @COMPOUND$ pretreatment, bivalirudin during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0
520	To determine whether a regimen of aspirin pretreatment, bivalirudin during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and @COMPOUND$ (10 nM).	0
521	To determine whether a regimen of aspirin pretreatment, bivalirudin during the procedure and @COMPOUND$ (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0
522	To determine whether a regimen of aspirin pretreatment, @COMPOUND$ during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to @PROTEIN$ (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).	0
523	The enzyme deoxyuridine 5'-triphosphate nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1
524	The enzyme @PROTEIN$ (dUTPase) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1
525	In the present study we perform a kinetic analysis of Campylobacter @PROTEIN$ using the continuous spectrophotometric method and show that the enzyme is highly specific for @COMPOUND$ nucleotides.	1
526	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan pyruvate, @COMPOUND$ and indole.	1
527	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from @COMPOUND$ pyruvate, ammonia and indole.	1
528	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan @COMPOUND$, ammonia and indole.	1
529	@PROTEIN$ allows soil microorganisms to use @COMPOUND$ as a source of nitrogen and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	1
530	@PROTEIN$ allows soil microorganisms to use urea as a source of @COMPOUND$ and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	0
531	Diastolic function and @PROTEIN$ changes during exercise predict @COMPOUND$ consumption in chronic heart failure patients.	1
532	Indoleamine 2,3-dioxygenase (@PROTEIN$) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1
533	@PROTEIN$ (IDO) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1
534	Type I @PROTEIN$ (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl) @COMPOUND$ bonds, is the key protein responsible for generation of the crosslinks.	1
535	@PROTEIN$-oncogene inactivating effect by @COMPOUND$ rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.	1
536	Caspase inhibition with z-@COMPOUND$ was unable to prevent @PROTEIN$ localization to the nucleus and subsequently unable to prevent cell death.	0
537	We have previously demonstrated that @COMPOUND$, a stable prostacyclin (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	1
538	We have previously demonstrated that iloprost, a stable @COMPOUND$ (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	0
539	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and @PROTEIN$ upregulation are modulated by peroxisome proliferator-activated receptor-alpha (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
540	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by peroxisome proliferator-activated receptor-alpha (@PROTEIN$), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
541	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by @PROTEIN$ (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
542	In contrast, @COMPOUND$ induces a robust angiogenic response in wild-type mice, along with local upregulation of @PROTEIN$.	1
543	Importantly, mice lacking the PPARalpha gene exhibit a normal angiogenic response to @PROTEIN$, indicating that the absence of PPARalpha does not result in a general impairment of angiogenesis, but specifically affects the ability of @COMPOUND$ to induce angiogenesis.	1
544	The proportion of @PROTEIN$ molecules that are directed to the novel cleavage pathway is regulated by the ratio of free @COMPOUND$ and cholesteryl esters in cells.	1
545	These findings suggest that multiple variations in the @PROTEIN$ gene are associated with remission in white non-Hispanic depressed adults treated with @COMPOUND$.	1
546	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to @PROTEIN$ with decreased affinity and binding enthalpy compared with RyR1.	0
547	At 0.15 microM @COMPOUND$+), ((35)S) @PROTEIN$ bound to RyR2 with decreased affinity and binding enthalpy compared with RyR1.	0
548	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to RyR2 with decreased affinity and binding enthalpy compared with @PROTEIN$.	0
549	The rates of ((35)S) CaM dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from @PROTEIN$ was little affected.	0
550	The rates of ((35)S) CaM dissociation from @PROTEIN$ increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
551	The rates of ((35)S) @PROTEIN$ dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
552	In rats, infusion of angiotensin II increases @PROTEIN$ levels and arterial thickness which are reversed by treatment with the iron chelator @COMPOUND$.	1
553	Furthermore, @COMPOUND$ regulated endogenous survival signaling by up-regulating phosphorylated @PROTEIN$ that returned to its basal level later.	1
554	Furthermore, @COMPOUND$ induced nucleus translocalization of p53 and @PROTEIN$ and recruitment of autophagosomes.	1
555	Furthermore, @COMPOUND$ induced nucleus translocalization of @PROTEIN$ and Akt and recruitment of autophagosomes.	1
556	Recent findings indicate that the polypyrimidine tract-binding protein (@PROTEIN$), also named hnRNP I, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the @COMPOUND$-induced increase in preproinsulin mRNA.	1
557	Recent findings indicate that the polypyrimidine tract-binding protein (PTB), also named @PROTEIN$, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the @COMPOUND$-induced increase in preproinsulin mRNA.	1
558	Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by @COMPOUND$ and inhibited by tamoxifen.	0
559	Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by estradiol and inhibited by @COMPOUND$.	0
560	This study was performed to investigate the effect of combined treatment with @COMPOUND$ and chromium on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0
561	This study was performed to investigate the effect of combined treatment with niacin and @COMPOUND$ on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and @PROTEIN$.	0
562	In HF group, the serum levels of total @COMPOUND$ (TC), low-density lipoprotein (LDL), oxidized low-density lipoprotein (ox-LDL) and endothelin (ET) were higher, whereas the levels of @PROTEIN$ (HDL), serum NO were lower than those in CG group.	0
563	These findings indicated that combined treatment with niacin and @COMPOUND$ has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1
564	These findings indicated that combined treatment with @COMPOUND$ and chromium has potential therapeutic protection of endothelial function by down-regulating ox-LDL/@PROTEIN$ signaling pathway.	1
565	The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type @PROTEIN$ from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded @COMPOUND$ residues that define the CRD and two additional cysteine residues at the amino terminus.	1
566	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and @PROTEIN$ (SOD) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
567	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and superoxide dismutase (@PROTEIN$) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
568	The experiment also indicated that catalase (@PROTEIN$) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
569	The experiment also indicated that @PROTEIN$ (CAT) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
570	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
571	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
572	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
573	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
574	On the other hand, @COMPOUND$ increased the expression of @PROTEIN$, involved in the regulation of proliferation.	1
575	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of @COMPOUND$, @PROTEIN$ expression, which induced apoptosis in a caspase-independent manner.	1
576	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of @PROTEIN$ and, in the case of @COMPOUND$, SIRT2 expression, which induced apoptosis in a caspase-independent manner.	0
577	Whereas both peptides @COMPOUND$ (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic gentamicin.	0
578	Whereas both peptides lactoferricin (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic @COMPOUND$.	0
579	Following thermal denaturation, rabbit reticulocyte lysate and @COMPOUND$ were added and @PROTEIN$ activity measured.	0
580	These results are in contrast to postmortem findings in schizophrenia and suggest that reduced @PROTEIN$ protein levels in schizophrenia patients' postmortem brain do not result from perinatal @COMPOUND$ deprivation.	0
581	However, OPN-(/-) mice showed increased serum levels of tumour necrosis factor (@PROTEIN$)-alpha, which could be due to systemically present @COMPOUND$ translocated to the gut.	1
582	However, @PROTEIN$-(/-) mice showed increased serum levels of tumour necrosis factor (TNF)-alpha, which could be due to systemically present @COMPOUND$ translocated to the gut.	1
583	@COMPOUND$ reduces induction of @PROTEIN$ and apoptosis in UVB-irradiated human skin independent of transcriptional controls.	1
584	We found that while OM24 treatment did not significantly affect UV-induced erythema and @COMPOUND$ dimer formation, OM24 treatment significantly reduced UV-induced @PROTEIN$ expression in keratinocytes.	0
585	Of various agents tested in HaCaT cell cultures, only @COMPOUND$ (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1
586	Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and @COMPOUND$ (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1
587	Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or @COMPOUND$ were without effect.	0
588	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
589	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
590	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
591	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
592	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
593	Plasma total @COMPOUND$, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
594	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
595	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
596	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
597	The increase of mature @PROTEIN$ by macrophages was inhibited by @COMPOUND$ : caspase-1 is known to cleave the proform of IL-18 to produce active mature IL-18.	1
598	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of @PROTEIN$ and TNF-alpha.	1
599	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of IL-6 and @PROTEIN$.	1
600	Dopamine release and direct stimulation of dopamine D2 and serotonin @PROTEIN$ receptors also contributes to the overall action of @COMPOUND$.	1
601	Our findings suggest that @COMPOUND$ differentially affects higher cognitive functions, but does not support the hypothesis from animal studies, that some of the MDMA effects are causally mediated through action at the @PROTEIN$ receptor system.	0
602	These results suggest that @PROTEIN$ does not play a significant role in clinical and functional manifestations in patients with schizophrenia who receive @COMPOUND$ treatment.	0
603	@COMPOUND$ (H2S) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
604	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
605	@COMPOUND$ (H2S) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
606	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
607	According to @PROTEIN$-binding, arsenic trioxide (7 microM) within 48 h significantly increased @COMPOUND$ exposure of human erythrocytes without inducing hemolysis.	0
608	Removal of extracellular Ca2+ or inhibition of the Ca2+-permeable cation channels with @COMPOUND$ blunted the effects of arsenic on @PROTEIN$-binding and cell shrinkage.	1
609	Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0
610	Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0
611	Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low @COMPOUND$ (rT3) levels.	1
612	Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low 3,3',5'-triiodothyronine (@COMPOUND$) levels.	1
613	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and @PROTEIN$ (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
614	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, @PROTEIN$, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
615	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and @PROTEIN$) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
616	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, @PROTEIN$-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
617	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (@PROTEIN$, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
618	In utero exposure to @COMPOUND$ reduced intratesticular T of foetal males (significant at 0.3 microg/kg TCDD) and tended to reduce the protein expression of @PROTEIN$ and AR of foetal male rat testis.	1
619	mRNA expression of developmental regulatory factors was not influenced by foetal @COMPOUND$ exposure, except for significantly reduced adrenal @PROTEIN$.	1
620	@COMPOUND$-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	0
621	Nitrogen-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the @COMPOUND$ biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	1
622	hsBAFF-upregulated intracellular free @COMPOUND$+) homeostasis regulates @PROTEIN$/2 activity and cell proliferation in B cells in vitro.	1
623	Using immunocytochemistry and Western blot analysis, we found that the activation of @PROTEIN$/2 due to hsBAFF was triggered by a (@COMPOUND$+))(i)-dependent pathway, leading to elevation of B cell proliferation.	1
624	This is supported by the findings that intracellular Ca(2+) chelator @COMPOUND$ attenuated phosphorylated @PROTEIN$/2 expression and cell proliferation in hsBAFF-stimulated B cells.	1
625	Taken together, the main finding of this study is that hsBAFF elicits higher but homeostatic (@COMPOUND$+))(i) levels, which regulates @PROTEIN$/2 activity and cell proliferation in in vitro B cells.	1
626	The enzyme @PROTEIN$ (IDO) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
627	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
628	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
629	The enzyme @PROTEIN$ (IDO) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
630	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
631	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
632	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
633	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
634	Peripheral administration of the acetylcholinesterase inhibitor @COMPOUND$ significantly reduced serum @PROTEIN$ levels through vagus nerve signaling, and protected against lethality during murine endotoxemia.	1
635	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of TNF by @COMPOUND$, indicating that suppressing @PROTEIN$ activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
636	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of @PROTEIN$ by @COMPOUND$, indicating that suppressing acetylcholinesterase activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
637	Administration of @COMPOUND$ to alpha7nAChR knockout mice failed to suppress @PROTEIN$ levels, indicating that the alpha7nAChR-mediated cholinergic anti-inflammatory pathway is required for the anti-inflammatory effect of galantamine.	0
638	The involvement of @COMPOUND$ and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
639	The involvement of superoxide and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (@COMPOUND$ and PTIO, respectively).	1
640	The involvement of superoxide and @COMPOUND$ was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
641	Accordingly, @PROTEIN$ were blocked by the peroxynitrite scavenger @COMPOUND$ and could be mimicked by application of exogenous peroxynitrite.	1
642	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (oleic acid, @COMPOUND$).	1
643	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (@COMPOUND$, Triton X-100).	1
644	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (@PROTEIN$ (2)) release and cyclooxygenase-2 (COX-2) expression in bovine synovial fibroblasts (SFs).	0
645	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and cyclooxygenase-2 (@PROTEIN$) expression in bovine synovial fibroblasts (SFs).	0
646	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and @PROTEIN$ (COX-2) expression in bovine synovial fibroblasts (SFs).	0
647	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with @COMPOUND$ or LY294002 improved apoptosis in the resistant cell lines.	1
648	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or @COMPOUND$ improved apoptosis in the resistant cell lines.	1
649	@PROTEIN$/Akt activity, analyzed by @COMPOUND$ trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or LY294002 improved apoptosis in the resistant cell lines.	1
650	Vincristine but not @COMPOUND$ increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	0
651	@COMPOUND$ but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	1
652	Vincristine but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and @COMPOUND$ increased apoptosis in the three cell lines.	0
653	Wortmannin and @COMPOUND$ inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
654	@COMPOUND$ and LY294002 inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
655	Namely, the results obtained for the most active compounds, 5-(chloroacetylamino) uracil (2) and its acyclic sugar analogue 18, suggest that formation of a covalent bond between reactive substituent and several possible targets within the @PROTEIN$ mechanism (sulphur of the @COMPOUND$ residue, basic part of the enzyme, N,N-methylene tetrahydrofolate or its reactive iminium forms) is the most probable mode of action.	1
656	Recent evidence for toxic @COMPOUND$ (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of @PROTEIN$ to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.	1
657	Two infants with elevated serum @PROTEIN$ had a decreased serum @COMPOUND$.	1
658	The allatostatins (@PROTEIN$), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
659	The @PROTEIN$ (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
660	The allatostatins (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are @PROTEIN$ that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	0
661	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-REIC treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-@PROTEIN$ expression.	0
662	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-@PROTEIN$ treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-glycoprotein expression.	0
663	Ad-REIC treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through @PROTEIN$ activation, and sensitized its drug resistance against @COMPOUND$.	0
664	Ad-REIC treatment in MCF7/ADR cells also downregulated P-@PROTEIN$ expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	0
665	Ad-@PROTEIN$ treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	1
666	@COMPOUND$, a homocamptothecin, targets @PROTEIN$.	1
667	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for morphine, @COMPOUND$ or food.	1
668	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for @COMPOUND$, cocaine or food.	1
669	Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater @PROTEIN$ induction in association with elevated @COMPOUND$ preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.	0
670	Exposure to @COMPOUND$ for 6 h induced expression of both caveolin-1 and cyclooxygenase (@PROTEIN$)-2.	1
671	Exposure to @COMPOUND$ for 6 h induced expression of both @PROTEIN$ and cyclooxygenase (COX)-2.	1
672	Pretreatment with @COMPOUND$ blocked fatty-acid-induced @PROTEIN$ and COX-2 expression in a time- and concentration-dependent manner.	1
673	Pretreatment with @COMPOUND$ blocked fatty-acid-induced caveolin-1 and @PROTEIN$ expression in a time- and concentration-dependent manner.	1
674	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including @PROTEIN$, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
675	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (@PROTEIN$), with maximal induction at about 10 min.	1
676	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, @PROTEIN$/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
677	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (@PROTEIN$/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
678	Inhibitors of ERK1/2 and Akt down-regulated the @COMPOUND$-induced increase in @PROTEIN$ protein, which also occurred after pretreatment with EGCG.	1
679	Inhibitors of ERK1/2 and Akt down-regulated the linoleic-acid-induced increase in @PROTEIN$ protein, which also occurred after pretreatment with @COMPOUND$.	1
680	Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of @PROTEIN$/2 and protein expression of COX-2, suggesting that specific MAPK signaling is caveolae dependent.	1
681	@PROTEIN$ silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of COX-2, suggesting that specific MAPK signaling is caveolae dependent.	0
682	Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of COX-2, suggesting that specific @PROTEIN$ signaling is caveolae dependent.	1
683	Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of @PROTEIN$, suggesting that specific MAPK signaling is caveolae dependent.	1
684	Therefore, we next examined whether @PROTEIN$ and 5-HT2C receptors are involved, and from where 5-HT is released in the @COMPOUND$ test.	0
685	Therefore, we next examined whether @COMPOUND$2A and @PROTEIN$ receptors are involved, and from where 5-HT is released in the formalin test.	0
686	Therefore, we next examined whether 5-HT2A and @PROTEIN$ receptors are involved, and from where 5-HT is released in the @COMPOUND$ test.	0
687	These results indicate that @COMPOUND$ released into peripheral tissue and its receptors, @PROTEIN$ as well as 5-HT2C, at the periphery have an important role in pain-related behaviors during acute peripheral inflammation.	1
688	These results indicate that @COMPOUND$ released into peripheral tissue and its receptors, 5-HT2A as well as @PROTEIN$, at the periphery have an important role in pain-related behaviors during acute peripheral inflammation.	1
689	@COMPOUND$ strongly decreased the expression of @PROTEIN$ 0.01).	1
690	In contrast, the administration of @COMPOUND$ significantly attenuated the immobilization stress-induced decrease in @PROTEIN$ 0.01).	1
691	@COMPOUND$ exhibited differential effects on @PROTEIN$ mRNA expression in the rat hippocampus and neocortex.	1
692	These results suggest that @COMPOUND$ might have a neuroprotective effect by recovering stress-induced decreases in @PROTEIN$ mRNA expression.	1
693	Leptin and soluble @PROTEIN$ receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
694	@PROTEIN$ and soluble leptin receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
695	Leptin and soluble @PROTEIN$ receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
696	@PROTEIN$ and soluble leptin receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
697	These vessels are formed by proliferating cells that incorporate @COMPOUND$ and express the endothelial cell markers vegfr2/@PROTEIN$ and fli1.	0
698	These vessels are formed by proliferating cells that incorporate @COMPOUND$ and express the endothelial cell markers vegfr2/kdr and @PROTEIN$.	0
699	Moreover, similar to rFGF2, injection of the zebrafish form of @PROTEIN$ (VEGF-A) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor @COMPOUND$.	1
700	Moreover, similar to rFGF2, injection of the zebrafish form of vascular endothelial growth factor-A (@PROTEIN$) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor @COMPOUND$.	1
701	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/@PROTEIN$ (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1
702	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and @PROTEIN$ (MAPKs) by reducing oxidative stress in aged rats.	1
703	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and mitogen-activated protein kinases (@PROTEIN$) by reducing oxidative stress in aged rats.	1
704	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (@PROTEIN$)/IkappaB kinase (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1
705	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory @PROTEIN$, iNOS, VCAM-1 and ICAM-1.	1
706	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, iNOS, @PROTEIN$ and ICAM-1.	1
707	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, @PROTEIN$, VCAM-1 and ICAM-1.	1
708	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, iNOS, VCAM-1 and @PROTEIN$.	1
709	The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of @PROTEIN$/IKK and MAPKs.	1
710	The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of NIK/IKK and @PROTEIN$.	1
711	Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of @PROTEIN$/IKK and MAPKs in vivo.	1
712	Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of NIK/IKK and @PROTEIN$ in vivo.	1
713	@COMPOUND$ is a free radical molecule synthesized from L-arginine by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
714	Nitric oxide is a free radical molecule synthesized from @COMPOUND$ by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
715	Furthermore, restoration of KSR1 expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased @PROTEIN$/2 activation following exposure to these drugs.	0
716	Furthermore, restoration of @PROTEIN$ expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased ERK1/2 activation following exposure to these drugs.	1
717	We demonstrated the increase in the levels of p53, Bax, and @PROTEIN$ and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
718	We demonstrated the increase in the levels of p53, Bax, and cytochrome c and decrease in the level of @PROTEIN$, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
719	We demonstrated the increase in the levels of p53, @PROTEIN$, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
720	We demonstrated the increase in the levels of @PROTEIN$, Bax, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
721	GFP-fluorescent cells were slowly cycling, as shown by their long-term retention of @COMPOUND$, and less than 10% expressed the proliferative markers Ki67 and @PROTEIN$.	0
722	@PROTEIN$ gene polymorphisms and high levels of @COMPOUND$ are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	0
723	Hypothetically, @PROTEIN$ influences the transport of @COMPOUND$ across the blood-brain barrier.	1
724	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, @PROTEIN$, ERG11, ERG24, ERG25 and ERG26.	1
725	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, @PROTEIN$, ERG24, ERG25 and ERG26.	1
726	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including @PROTEIN$, ERG7, ERG11, ERG24, ERG25 and ERG26.	1
727	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, @PROTEIN$ and ERG26.	1
728	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, ERG25 and @PROTEIN$.	1
729	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, @PROTEIN$, ERG25 and ERG26.	1
730	While it is clearly demonstrated that members of the @PROTEIN$/6/7 subfamily are activated by @COMPOUND$, the mechanism by which phospholipase C activates members of the TRPC1/4/5 subfamily remains a mystery.	1
731	While it is clearly demonstrated that members of the TRPC3/6/7 subfamily are activated by @COMPOUND$, the mechanism by which phospholipase C activates members of the @PROTEIN$/4/5 subfamily remains a mystery.	0
732	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of @PROTEIN$ activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or TRPC7-expressing cells.	1
733	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in @PROTEIN$-or TRPC7-expressing cells.	0
734	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or @PROTEIN$-expressing cells.	0
735	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in @PROTEIN$-expressing but not in TRPC3-or TRPC7-expressing cells.	0
736	Inclusion of polyphosphatidylinositol 4-phosphate or PIP2, but not @COMPOUND$, in the patch pipette inhibited @PROTEIN$ currents.	0
737	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-D-galactopyranosyl and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-@COMPOUND$ residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
738	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-@COMPOUND$ and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-beta-D-glucose residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
739	Preliminary tests in vitro showed POP is capable of enhancing concanavalin A (@PROTEIN$)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
740	Preliminary tests in vitro showed @PROTEIN$ is capable of enhancing concanavalin A (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	1
741	Preliminary tests in vitro showed POP is capable of enhancing @PROTEIN$ (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
742	It was observed that administration of the PKC inhibitor @COMPOUND$ (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (PKCalpha, @PROTEIN$, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.	1
743	It was observed that administration of the PKC inhibitor @COMPOUND$ (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (@PROTEIN$, PKCdelta, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.	1
744	DNA sequences of a calmodulin (@PROTEIN$)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
745	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the @PROTEIN$ (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
746	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (@PROTEIN$) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
747	DNA sequences of a @PROTEIN$ (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
748	@PROTEIN$ protein contains high glycine and @COMPOUND$, which concerns regulation and function of the matrix structure fiber.	1
749	@PROTEIN$ protein contains high @COMPOUND$ and tyrosine, which concerns regulation and function of the matrix structure fiber.	1
750	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
751	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
752	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
753	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
754	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
755	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
756	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
757	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
758	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
759	Beta1,4-@PROTEIN$-I (B4GALT1), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
760	Beta1,4-galactosyltransferase-I (@PROTEIN$), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
761	Beta1,4-galactosyltransferase-I (B4GALT1), one of seven beta1,4-@PROTEIN$, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
762	When compared to the other mammalian @PROTEIN$ genes, the porcine coding sequence contained a single @COMPOUND$ codon inserted into the region encoding the cytoplasmic domain.	1
763	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
764	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
765	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
766	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
767	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
768	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
769	Induction of NY-ESO-1 expression on tumor targets using the demethylating agent 5-aza-2'-deoxycytidine (alone or in combination with the histone deacetylase inhibitor @COMPOUND$) resulted in enhanced @PROTEIN$ secretion by the TCR-transduced PBL on culture with treated targets.	1
770	Induction of NY-ESO-1 expression on tumor targets using the demethylating agent @COMPOUND$ (alone or in combination with the histone deacetylase inhibitor depsipeptide) resulted in enhanced @PROTEIN$ secretion by the TCR-transduced PBL on culture with treated targets.	1
771	Elevated beta1,4-@PROTEIN$-I induced by the intraspinal injection of @COMPOUND$.	1
772	E-selectin, which ligand was modified by beta1,4-@PROTEIN$-I, was correlated with @COMPOUND$-containing glycans following injecting LPS into spinal cord.	0
773	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-@COMPOUND$, (3)H-lysine, and (3)H-methylaminoisobutyric acid, respectively.	0
774	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-phenylalanine, (3)H-@COMPOUND$, and (3)H-methylaminoisobutyric acid, respectively.	0
775	We hypothesised that @PROTEIN$ could be a limiting step in @COMPOUND$-arginine interconversion.	1
776	We hypothesised that @PROTEIN$ could be a limiting step in glutamine-@COMPOUND$ interconversion.	1
777	@PROTEIN$ overexpression decreased plasma and liver @COMPOUND$ concentrations but did not affect glutamine or arginine homeostasis.	1
778	@PROTEIN$ overexpression decreased plasma and liver ornithine concentrations but did not affect @COMPOUND$ or arginine homeostasis.	0
779	@PROTEIN$ overexpression decreased plasma and liver ornithine concentrations but did not affect glutamine or @COMPOUND$ homeostasis.	0
780	There was an inverse relationship between @COMPOUND$ levels and @PROTEIN$ activity.	1
781	In men there is a large interindividual variation of @PROTEIN$ levels and consequently of @COMPOUND$ (T) and E(2) levels.	1
782	When the @PROTEIN$ concentration was higher than 15 U/mL, the gelation could be finished within 1 min and yielded a composite with evenly suspended and distributed @COMPOUND$ microspheres.	1
783	@PROTEIN$ inhibits toll-like receptor 3-induced @COMPOUND$ production in Schwann cells and subsequent sensory neuronal cell death in vitro.	1
784	The aim of the present study was to examine whether increased serum Hsp70 levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (@PROTEIN$), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0
785	The aim of the present study was to examine whether increased serum @PROTEIN$ levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (fibronectin), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0
786	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
787	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
788	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
789	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
790	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
791	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
792	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
793	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
794	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
795	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
796	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
797	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
798	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
799	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of @PROTEIN$ :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
800	Furthermore, serum levels of blood urea @COMPOUND$, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
801	Furthermore, serum levels of blood urea nitrogen, creatinine, @COMPOUND$ and @PROTEIN$, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
802	Furthermore, serum levels of blood @COMPOUND$ nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
803	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
804	Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, @PROTEIN$, cell-free fetal DNA and @COMPOUND$ were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
805	Furthermore, serum levels of blood urea nitrogen, @COMPOUND$, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (@PROTEIN$) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	0
806	In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum @PROTEIN$ levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0
807	In preeclamptic patients, serum @PROTEIN$ levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	1
808	In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum @PROTEIN$ (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0
809	In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and @PROTEIN$ (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0
810	Four different molecules contain galactofuranose in A. fumigatus: (i) the @COMPOUND$ present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0
811	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an @COMPOUND$.	0
812	Four different molecules contain galactofuranose in A. fumigatus: (i) the @COMPOUND$ present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0
813	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O @COMPOUND$ moieties of secreted @PROTEIN$ (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	1
814	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an @COMPOUND$.	0
815	Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O @COMPOUND$ moieties of secreted glycoproteins (iii) a @PROTEIN$-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.	0
816	The estimated @PROTEIN$ level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral @COMPOUND$ load serum insulin levels and other surrogate markers of insulin resistance.	0
817	The estimated CRP level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral @COMPOUND$ load serum @PROTEIN$ levels and other surrogate markers of insulin resistance.	1
818	The @PROTEIN$-induced up-regulation of RhoA was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (STAT6).	0
819	The IL-13-induced up-regulation of @PROTEIN$ was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (STAT6).	1
820	The IL-13-induced up-regulation of RhoA was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (@PROTEIN$).	1
821	It represents transition in @COMPOUND$-deprived conditions, known to lead to H2 production in Chlamydomonas reinhardtii, and the two main processes then induced which are an over-accumulation of intracellular starch and a progressive reduction of @PROTEIN$ activity for anoxia achievement.	1
822	Macrophages isolated from iron deficient rats, or pregnant rats at day 21 of gestation, either supplemented with a single dose of @COMPOUND$, 10 mg, at the commencement of pregnancy, or not, showed significant increases of macrophage ferroportin mRNA expression, which was paralleled by significant decreases in hepatic @PROTEIN$ mRNA expression.	1
823	Calcineurin inhibitors (CsA, @COMPOUND$ and pimecrolimus) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
824	Calcineurin inhibitors (CsA, FK-506 and @COMPOUND$) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
825	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (FK-506) and @COMPOUND$ inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
826	In conclusion, the results suggest that calcineurin inhibitors @COMPOUND$, tacrolimus (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
827	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, @COMPOUND$ (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
828	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (@COMPOUND$) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
829	Accumulation of @COMPOUND$ in PA was increased by @PROTEIN$ at 10nM and by IGF-I at 1 nM and 10nM.	1
830	Accumulation of @COMPOUND$ in PA was increased by insulin at 10nM and by @PROTEIN$ at 1 nM and 10nM.	1
831	The activity of guanylyl @PROTEIN$ was determined by the amount of @COMPOUND$ generated in responses to sodium nitroprusside (SNP) or ANP.	1
832	Almost all @PROTEIN$ kinase that translocates to the nucleus shows a marked phosphorylation on @COMPOUND$ 473.	1
833	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the @COMPOUND$ residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
834	@COMPOUND$-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
835	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of @COMPOUND$ to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
836	A D-amino acid oxidase gene (dao) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of @PROTEIN$ without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
837	A D-amino acid oxidase gene (@PROTEIN$) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of DAAO without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
838	PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$s may be a principal mechanism by which FGF signaling affects bone mineralization.	1
839	PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$ may be a principal mechanism by which FGF signaling affects bone mineralization.	1
840	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce @COMPOUND$ from xylose while metabolizing glucose (Cirino et al.	1
841	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce xylitol from xylose while metabolizing @COMPOUND$ (Cirino et al.	1
842	Studies in which the expression of CbXR or a @PROTEIN$ was increased suggest that enzyme activity and xylose transport are not limiting @COMPOUND$ production in PC09.	1
843	For the case of xylose-proton symport, omitting the @PROTEIN$ (glucose-6-phosphate dehydrogenase) or PntAB (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
844	For the case of xylose-proton symport, omitting the Zwf (glucose-6-phosphate dehydrogenase) or @PROTEIN$ (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
845	Experimentally, deleting pgi (encoding @PROTEIN$) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
846	Experimentally, deleting @PROTEIN$ (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
847	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (@PROTEIN$ and pntA) has no significant effect on the measured yield.	0
848	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and @PROTEIN$) has no significant effect on the measured yield.	0
849	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
850	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
851	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
852	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
853	The cell proliferation, the up-regulation of pS2, and the down-regulation of @PROTEIN$ and ERbeta gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1
854	The cell proliferation, the up-regulation of pS2, and the down-regulation of ERalpha and @PROTEIN$ gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1
855	The considered biological model system consisted of a coating antibody (goat IgG), bovine serum albumin (@PROTEIN$) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0
856	The considered biological model system consisted of a coating antibody (goat IgG), bovine @PROTEIN$ (BSA) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0
857	Acylation-stimulating protein (@PROTEIN$) has been shown to positively stimulate fatty acid esterification and @COMPOUND$ uptake in adipocytes.	1
858	Serum @COMPOUND$ (E2) levels were not altered at any time point after @PROTEIN$, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.	0
859	In addition, treatment of primary mouse lung fibroblasts with @COMPOUND$ stimulated @PROTEIN$ activity and collagen formation in vitro.	1
860	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through NOS inhibition and enhancement of @PROTEIN$ activity.	1
861	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through @PROTEIN$ inhibition and enhancement of arginase activity.	1
862	Osteopontin (@PROTEIN$) inhibits the growth of @COMPOUND$ (COM) and other crystal phases in a phosphorylation-dependent manner.	1
863	Prostaglandins D2, E2, and F2alpha were increased in the tissues from mouse pups exposed to &gt;95% @COMPOUND$ at 7 d indicating a differential expression of @PROTEIN$ products.	1
864	These data confirm that endogenous miR-34a regulates @PROTEIN$ levels and supports the notion that miR-34a contributes to the effects of @COMPOUND$ and VPA on GRM7.	1
865	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with mPEG-@COMPOUND$ (mPEG-Suc, 5 kDa).	1
866	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble @COMPOUND$ derivative at Cys 1 and Cys 7, was reacted with mPEG-succinimide (mPEG-Suc, 5 kDa).	1
867	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with @COMPOUND$-succinimide (mPEG-Suc, 5 kDa).	1
868	Our findings suggest that @PROTEIN$ substituted with a PEG of an appropriate Mw at Lys (34) could be used as a promising type 2 anti-diabetic agent to timely control postprandial @COMPOUND$ levels.	1
869	The antidepressant @COMPOUND$ blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (@PROTEIN$) expression in the hippocampus of rats.	1
870	Intravenous @COMPOUND$ enhances @PROTEIN$ activity giving cardioprotection.	1
871	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (COX)-2 and heat shock protein (@PROTEIN$) 72, might induce preconditioning.	1
872	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (@PROTEIN$)-2 and heat shock protein (HSP) 72, might induce preconditioning.	1
873	Furthermore, treatment of @COMPOUND$ and EPA also synergistically blocked the activation of downstream @PROTEIN$ molecule.	1
874	Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as @PROTEIN$ and Fas ligand to suppress cell survival.	1
875	Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as Bax and @PROTEIN$ to suppress cell survival.	1
876	The NSCs and neuroblasts had epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor alpha (@PROTEIN$) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
877	The NSCs and neuroblasts had @PROTEIN$ (EGFR) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
878	The NSCs and neuroblasts had epidermal growth factor receptor (@PROTEIN$) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
879	Ependymal and displaced ependymal cells also expressed EGFR and @PROTEIN$ on their cilia but did not incorporate @COMPOUND$.	0
880	Ependymal and displaced ependymal cells also expressed @PROTEIN$ and PDGFRalpha on their cilia but did not incorporate @COMPOUND$.	0
881	Furthermore, @PROTEIN$ overexpression reduced @COMPOUND$ anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls.	1
882	Furthermore, @PROTEIN$ overexpression reduced superoxide anion generation after H/R, whereas @COMPOUND$ levels were significantly improved compared with WT controls.	1
883	Associations between the uptake of 111In-@COMPOUND$-trastuzumab, @PROTEIN$ density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.	1
884	The purpose of the study was to investigate the associations between uptake of (111)In-@COMPOUND$-trastuzumab, tumour @PROTEIN$ density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.	1
885	The @COMPOUND$ (the final product of ATP hydrolysis by @PROTEIN$), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	1
886	To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, @PROTEIN$ (DHAPAT) activity, peroxisomal thiolase, and catalase immunofluorescence.	0
887	To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (DHAPAT) activity, peroxisomal thiolase, and @PROTEIN$ immunofluorescence.	0
888	To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (@PROTEIN$) activity, peroxisomal thiolase, and catalase immunofluorescence.	0
889	To this end, the cultured fibroblasts were analyzed for very @COMPOUND$ (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (DHAPAT) activity, peroxisomal @PROTEIN$, and catalase immunofluorescence.	0
890	Also, @PROTEIN$ induction and concomitant @COMPOUND$ generation appear to participate in the cytotoxicity of excessive portal pressure after extended hepatectomy.	1
891	The interaction of quercetin, which is a @COMPOUND$, with bovine @PROTEIN$ (BSA) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
892	The interaction of @COMPOUND$, which is a bioflavonoid, with bovine @PROTEIN$ (BSA) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
893	The interaction of quercetin, which is a @COMPOUND$, with bovine serum albumin (@PROTEIN$) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
894	The interaction of @COMPOUND$, which is a bioflavonoid, with bovine serum albumin (@PROTEIN$) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	1
895	1x10(-5) mol L(-1)), most of the site marker reacted with the quercetin-@PROTEIN$, but free @COMPOUND$ was present at higher concentrations.	0
896	Under optimum conditions, the fluorescence intensity of @PROTEIN$-GNPs is linearly proportional to @COMPOUND$ concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.	1
897	Among the Gram-negative bacteria, 100% of the Escherichia coli isolates (including extended spectrum @PROTEIN$ (ESBL)-producers) were @COMPOUND$-susceptible, while about 10% of the Enterobacter cloacae and Klebsiella pneumoniae isolates were resistant.	1
898	The data presented here show that NH4Cl (5 mM) mediates astroglial cell swelling, and that treatment with NH4Cl or @COMPOUND$ (25 mM) causes rearrangements of @PROTEIN$ filaments and reduces astroglial glutamate uptake capacity.	1
899	Decreased expression of @PROTEIN$, the binding site for @COMPOUND$, during epileptogenesis and chronic epilepsy.	1
900	We previously showed that gene expression of @PROTEIN$ (SV2A), the binding site for the antiepileptic drug @COMPOUND$, is reduced during epileptogenesis in the rat.	1
901	We previously showed that gene expression of synaptic vesicle protein 2A (@PROTEIN$), the binding site for the antiepileptic drug @COMPOUND$, is reduced during epileptogenesis in the rat.	1
902	Treatment with @COMPOUND$ resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of @PROTEIN$.	1
903	Obesity increases @PROTEIN$ resistance and @COMPOUND$ intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes.	0
904	Inhibition of @PROTEIN$ kinase by @COMPOUND$ : Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.	1
905	The investigation included simulated docking experiments to fit @COMPOUND$ within the binding pocket of @PROTEIN$ followed by experimental in vitro and in vivo validations.	1
906	@COMPOUND$ was found to optimally fit within the binding pocket of @PROTEIN$ via several attractive interactions with key amino acids.	1
907	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
908	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
909	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
910	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
911	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
912	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
913	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
914	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
915	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
916	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
917	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
918	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
919	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	0
920	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
921	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
922	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
923	Crustacean hyperglycemic hormone (@PROTEIN$) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
924	@PROTEIN$ (CHH) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
925	In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent Cl (-) secretion and predominant @COMPOUND$ (+) absorption.	1
926	In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient @COMPOUND$-dependent Cl (-) secretion and predominant Na (+) absorption.	1
927	In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent Cl (-) secretion and predominant @COMPOUND$ (+) absorption.	1
928	In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient @COMPOUND$-dependent Cl (-) secretion and predominant Na (+) absorption.	1
929	In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (@PROTEIN$) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent @COMPOUND$ (-) secretion and predominant Na (+) absorption.	1
930	In cystic fibrosis, this equilibrium is disrupted by mutations in the @PROTEIN$ (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent @COMPOUND$ (-) secretion and predominant Na (+) absorption.	1
931	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood @COMPOUND$ and low @PROTEIN$ cholesterol were not.	0
932	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood glucose and low @PROTEIN$ @COMPOUND$ were not.	1
933	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (@PROTEIN$), in the extended amygdala.	1
934	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as @PROTEIN$ (CRF), in the extended amygdala.	1
935	On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to @COMPOUND$ or erlotinib.	1
936	On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to gefitinib or @COMPOUND$.	1
937	Here, we tested the hypothesis that interactions with @PROTEIN$ play a role in the DNA-damaging properties of @COMPOUND$.	0
938	Next, we selected @COMPOUND$ as the most DNA-damaging Alternaria metabolite for further studies of interactions with @PROTEIN$.	0
939	Stabilisation of covalent @PROTEIN$ II-DNA intermediates by @COMPOUND$ was also detectable in cell culture, and here, the IIalpha isoform was preferentially targeted.	1
940	Bone formation and maturation processes were evaluated by double staining for alkaline @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
941	Bone formation and maturation processes were evaluated by double staining for alkaline phosphatase and tartrate-resistant acid phosphatase, immunohistochemistry for bone @PROTEIN$, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
942	Bone formation and maturation processes were evaluated by double staining for @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
943	Phosphorylation of insulin receptor substrate (@PROTEIN$) proteins on @COMPOUND$ residues has emerged as a key step in these control processes under both physiological and pathological conditions.	1
944	Phosphorylation of @PROTEIN$ substrate (IRS) proteins on @COMPOUND$ residues has emerged as a key step in these control processes under both physiological and pathological conditions.	1
945	In contrast, SKI-1 (@PROTEIN$ or site-1) is a membrane-bound serine protease inhibitable by @COMPOUND$.	1
946	In contrast, @PROTEIN$ (S1P or site-1) is a membrane-bound serine protease inhibitable by @COMPOUND$.	1
947	In contrast, SKI-1 (S1P or site-1) is a membrane-bound @PROTEIN$ inhibitable by @COMPOUND$.	1
948	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to @COMPOUND$-glucose deprivation in murine neonatal organotypic hippocampal slices.	1
949	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-@COMPOUND$ deprivation in murine neonatal organotypic hippocampal slices.	1
950	The role of tumor necrosis factor (@PROTEIN$) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
951	The role of @PROTEIN$ (TNF) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
952	Accommodation of @COMPOUND$ and its analogues by @PROTEIN$ is dominated by hydrophobic interactions.	1
953	The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates pyridostigmine, @COMPOUND$ and several analogues of physostigmine, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1
954	The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates pyridostigmine, rivastigmine and several analogues of @COMPOUND$, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1
955	The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates @COMPOUND$, rivastigmine and several analogues of physostigmine, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1
956	Synaptic vesicle-bound @PROTEIN$ can support vesicular @COMPOUND$ uptake.	1
957	We present evidence that ATP generated by synaptic vesicle-associated @PROTEIN$ is harnessed to transport @COMPOUND$ into synaptic vesicles.	1
958	We examined the expression of @PROTEIN$ and ASCT1 in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
959	We examined the expression of Phgdh and @PROTEIN$ in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
960	In the present study the effect of the convulsant drug @COMPOUND$ (MP) repetitive administration (4-7 days) on the hippocampal @PROTEIN$ subunit was studied.	1
961	A significant decrease in @PROTEIN$ in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in @COMPOUND$ by western blot assay.	1
962	Heart glycogen represents a store of glucosyl residues which are mobilized by the catalysis of @PROTEIN$ (GP) and are mainly destined to serve as substrates for the generation of @COMPOUND$.	0
963	Tissues were stained for BrdU, @PROTEIN$, vimentin, and @COMPOUND$ and eosin staining.	0
964	Tissues were stained for @COMPOUND$, @PROTEIN$, vimentin, and haematoxylin and eosin staining.	0
965	Tissues were stained for @COMPOUND$, Pax-7, @PROTEIN$, and haematoxylin and eosin staining.	0
966	Tissues were stained for BrdU, Pax-7, @PROTEIN$, and @COMPOUND$ and eosin staining.	0
967	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by 5'-iodoresiniferatoxin (5 microg) or @PROTEIN$ was inhibited by @COMPOUND$ chloride (5 microg).	1
968	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by @COMPOUND$ (5 microg) or @PROTEIN$ was inhibited by chelerythrine chloride (5 microg).	0
969	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by 5'-iodoresiniferatoxin (5 microg) or @PROTEIN$ was inhibited by chelerythrine @COMPOUND$ (5 microg).	1
970	The recent approval of sunitinib, sorafenib, @COMPOUND$ and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0
971	The recent approval of sunitinib, @COMPOUND$, temsirolimus and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0
972	The recent approval of @COMPOUND$, sorafenib, temsirolimus and bevacizumab in combination with @PROTEIN$ has revolutionized the management of renal cell carcinoma.	0
973	In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of @COMPOUND$ (MeHg) and the association between @PROTEIN$ (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	0
974	In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of methylmercury (@COMPOUND$) and the association between @PROTEIN$ (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	0
975	H2S can be produced from @COMPOUND$ by enzymes such as @PROTEIN$.	1
976	The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-@PROTEIN$/c-jun heterodimers in spontaneous hypertensive rats (SHRs).	1
977	The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-fos/c-@PROTEIN$ heterodimers in spontaneous hypertensive rats (SHRs).	1
978	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), @PROTEIN$ (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or ferritin without AA.	0
979	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), HSF (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or @PROTEIN$ without AA.	0
980	Insulin-like growth factor-I (@PROTEIN$) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
981	@PROTEIN$-like growth factor-I (IGF-I) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
982	These data indicate that @PROTEIN$ may be a potential treatment for some of @COMPOUND$'s damaging effects, a finding that has important implications for children of women who drink alcohol during pregnancy.	1
983	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of glucose oxidase (@PROTEIN$), modified with beta-cyclodextrin.	1
984	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of @PROTEIN$ (GOX), modified with beta-cyclodextrin.	1
985	This allows the immobilization of @COMPOUND$-tagged @PROTEIN$.	1
986	Alkaline phosphatase activity and @PROTEIN$ expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
987	@PROTEIN$ activity and osteonectin expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
988	The @PROTEIN$ activity of osteoblasts cultured on @COMPOUND$ scaffolds is comparable with that from two commercially-available scaffolds-OPLA and collagen scaffolds (Becton-Dickinson (BD) Inc., Franklin Lakes, NJ, USA).	0
989	The vasodilating effect of @COMPOUND$ and dorzolamide involves mechanisms other than @PROTEIN$ inhibition.	0
990	The vasodilating effect of acetazolamide and @COMPOUND$ involves mechanisms other than @PROTEIN$ inhibition.	0
991	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
992	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
993	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
994	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
995	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant @PROTEIN$ and over-expressed EGFR.	1
996	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed @PROTEIN$.	1
997	In vitro effect of radiation, antibody to @PROTEIN$ and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR.	0
998	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/@COMPOUND$.	1
999	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by @COMPOUND$/HBTU.	1
1000	Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for @PROTEIN$-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
1001	Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for CGL2-@PROTEIN$-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
1002	Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for CGL2-@PROTEIN$-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
1003	Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for @PROTEIN$-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.	1
1004	Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-@COMPOUND$) structures and their characterization for CGL2-galectin-mediated binding of ECM @PROTEIN$ to biomaterial surfaces.	1
1005	Chemo-enzymatic synthesis of @COMPOUND$ (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM @PROTEIN$ to biomaterial surfaces.	1
1006	@COMPOUND$ (poly-LacNAc) structures have been identified as important ligands for @PROTEIN$-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	1
1007	Poly-N-acetyllactosamine (poly-@COMPOUND$) structures have been identified as important ligands for @PROTEIN$-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	1
1008	We here present the biofunctionalization of surfaces with poly-@COMPOUND$ structures and subsequent binding of ECM @PROTEIN$.	1
1009	A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model galectin His(6) @PROTEIN$.	1
1010	A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model @PROTEIN$ His(6) CGL2.	1
1011	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further @PROTEIN$-mediated binding of the ECM glycoproteins laminin and fibronectin.	1
1012	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the ECM glycoproteins laminin and @PROTEIN$.	1
1013	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the ECM @PROTEIN$ laminin and fibronectin.	1
1014	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the @PROTEIN$ glycoproteins laminin and fibronectin.	1
1015	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1016	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1017	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1018	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1019	These transcripts were predicted to synthesis of @PROTEIN$ proteins truncated of the binding site for @COMPOUND$, an essential cofactor, therefore cannot function as a decarboxylase.	1
1020	Activities of malate- and succinate-dehydrogenases (MDH, @PROTEIN$) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1
1021	Activities of malate- and succinate-dehydrogenases (@PROTEIN$, SDH) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1
1022	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, @PROTEIN$ (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1023	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (@PROTEIN$, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1024	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (@PROTEIN$), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1025	This paper investigates the effect of sterilisation by gamma irradiation (dose 2.5Mrad) on the following properties of @COMPOUND$ (PCL): (1) degradation rate (catalysed by @PROTEIN$), (2) mechanical properties, (3) the ability of cells to attach and subsequently grow on its surface.	1
1026	Specifically, animals were exposed to one of five dipsetic stimuli: (1) 24-h water deprivation, (2) replacement of drinking water with 2.5% @COMPOUND$, (3) peripheral administration of hypertonic saline, (4) ICV injection of angiotensin II (@PROTEIN$), or (5) the combination of peripheral hypertonic saline and central AngII.	0
1027	Specifically, animals were exposed to one of five dipsetic stimuli: (1) 24-h water deprivation, (2) replacement of drinking water with 2.5% @COMPOUND$, (3) peripheral administration of hypertonic saline, (4) ICV injection of @PROTEIN$ (AngII), or (5) the combination of peripheral hypertonic saline and central AngII.	0
1028	One hundred and forty-four HCV-2- and HCV-3-infected patients initiated Peg-@PROTEIN$-2a (180 microg/week) and @COMPOUND$ (1000 or 1200 mg/day); those with viral clearance at week 4 were randomized to either Peg-IFN alpha-2a monotherapy (n = 59) or continuing combination therapy (n = 61) until week 12.	0
1029	Thus in HCV-2- and HCV-3-infected patients, withdrawal of @COMPOUND$ and continuation of Peg-@PROTEIN$-2a monotherapy may be appropriate to attain an SVR, providing viraemia is cleared early during therapy and associated with low baseline viral load.	0
1030	The inhibitors include mitogen-inducible gene-6 (@PROTEIN$)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1031	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (@PROTEIN$).	0
1032	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/@PROTEIN$/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1033	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/@PROTEIN$, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1034	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, @PROTEIN$ (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1035	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (@PROTEIN$)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1036	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/@PROTEIN$, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1037	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/@PROTEIN$ (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1038	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (@PROTEIN$)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1039	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (@PROTEIN$)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1040	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
1041	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
1042	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
1043	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
1044	There are no controlled trials comparing @PROTEIN$ and @COMPOUND$ efficacy and therapeutic mechanisms in psoriasis.	0
1045	The picture of signalling mechanisms underlying the wound-regulated FAD7 expression, and potential roles of @PROTEIN$ proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
1046	The picture of signalling mechanisms underlying the wound-regulated @PROTEIN$ expression, and potential roles of CPL proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
1047	The aim of this study was to determine the effect of @COMPOUND$ on endothelial function in anti-tumour necrosis factor (@PROTEIN$)-naive RA patients.	1
1048	Effect of short-time exposures to @COMPOUND$ and lead on brain @PROTEIN$ from Danio rerio and Poecilia reticulata.	1
1049	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain monoamine oxidase (@PROTEIN$), an important neural enzyme.	1
1050	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain @PROTEIN$ (MAO), an important neural enzyme.	1
1051	Methylene@COMPOUND$ dehydrogenase) @PROTEIN$) formyltetrahydrofolate synthetase (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
1052	Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) formyltetrahydrofolate synthetase (@PROTEIN$) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
1053	Methylene@COMPOUND$ dehydrogenase) methenyltetrahydrofolate cyclohydrolase) @PROTEIN$ (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.	1
1054	Residue-wise conformational stability of @PROTEIN$ dimer from native-state @COMPOUND$ exchange.	1
1055	Whereas the role of locally produced 1, @COMPOUND$ is not yet clear, it is possible that it contributes importantly to vitamin D-mediated inhibition of parathyroid cell growth, so @PROTEIN$ can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	0
1056	Whereas the role of locally produced 1, 25-dihydroxy@COMPOUND$ is not yet clear, it is possible that it contributes importantly to vitamin D-mediated inhibition of parathyroid cell growth, so @PROTEIN$ can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	0
1057	We have investigated its antibacterial activity and binding activity to pathogenic whole cell antigens, @COMPOUND$ (LPS) and staphylococcal @PROTEIN$.	0
1058	Induction of the spliced form of @PROTEIN$ as well as total XBP1 by @COMPOUND$ was significantly attenuated in patients with BD.	1
1059	Induction of @PROTEIN$ by @COMPOUND$ was also decreased in the BD group.	1
1060	@COMPOUND$ attenuates antigen-specific IgE production through the modulation of @PROTEIN$/Th2 balance in ovalbumin-sensitized BALB/c mice.	1
1061	BALB/c mice were either left untreated or administered daily with vehicle (VH; saline) and/or @COMPOUND$ (200 or 400 mg/kg) by gavage for 3 consecutive days prior to sensitization with @PROTEIN$ (OVA).	0
1062	Despite their inhibitory effects on inflammatory gene expression, loss of @PROTEIN$ or LXRs in macrophages did not exert major effects on obesity or @COMPOUND$ tolerance induced by a high-fat diet.	0
1063	Our results do not exclude a contribution of macrophage @PROTEIN$ and LXR expression to systemic metabolism in certain contexts, but these factors do not appear to be dominant contributors to @COMPOUND$ tolerance in a high-fat-fed Th1-biased bone marrow transplant model.	0
1064	A mechanism for the bioreduction of H2PtCl6 and PtCl2 into @COMPOUND$ nanoparticles by a @PROTEIN$ enzyme from Fusarium oxysporum is proposed.	1
1065	The results indicated that @PROTEIN$ receptors within the nucleus accumbens are involved in the acquisition and expression of @COMPOUND$-induced CPP in sensitized rats.	1
1066	Effect of obestatin on insulin, @PROTEIN$ and @COMPOUND$ secretion in the perfused rat pancreas.	0
1067	Effect of @PROTEIN$ on insulin, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	1
1068	Effect of obestatin on @PROTEIN$, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	0
1069	The potentiated effect of obestatin on @COMPOUND$-induced @PROTEIN$ output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1070	The potentiated effect of @PROTEIN$ on @COMPOUND$-induced insulin output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1071	The potentiated effect of obestatin on glucose-induced @PROTEIN$ output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1072	The potentiated effect of @PROTEIN$ on glucose-induced insulin output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1073	We administered @COMPOUND$ to newborn rats on postnatal days (PN) 1-4 at doses spanning the threshold for detectable @PROTEIN$ inhibition (0.1 mg/kg/day) and the first signs of loss of viability (0.2 mg/kg/day).	1
1074	The Arg105 in @PROTEIN$ is highly conserved across species and its replacement with @COMPOUND$ is predicted to be pathogenic.	1
1075	High-dose steroid therapy for the former symptoms of AHS, and immunoglobulin, @PROTEIN$, and @COMPOUND$ for the latter agranulocytosis were successfully performed.	0
1076	0.05 vs. aortic IR) plasma levels of @COMPOUND$, P-selectin, intercellular adhesion molecule-1 (ICAM-I), and tissue levels of malondialdehyde and @PROTEIN$.	0
1077	Drosophila responds to detection of diamonopimelic-type microbial @COMPOUND$ through activation of the immune deficiency (Imd) pathway, a signaling pathway with numerous similarities to the mammalian pro-inflammatory @PROTEIN$ pathway.	1
1078	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1079	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1080	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, @PROTEIN$, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1081	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1082	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1083	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1084	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1085	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1086	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1087	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0
1088	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, @PROTEIN$ (HDL), triglycerides and parathormone).	0
1089	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1090	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1091	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
1092	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1093	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1094	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1095	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0
1096	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
1097	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1098	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1099	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
1100	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1101	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
1102	Serum @COMPOUND$ (25-OHD), calcium, @PROTEIN$ and phosphorus were measured.	0
1103	Serum 25-hydroxyvitamin D (25-OHD), calcium, @PROTEIN$ and @COMPOUND$ were measured.	0
1104	@COMPOUND$-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by resveratrol.	0
1105	Conjugated linoleic acid-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by @COMPOUND$.	1
1106	Inflammation plays a role in trans-10, cis-12 (10,12)-@COMPOUND$ (CLA)-mediated delipidation and @PROTEIN$ resistance in adipocytes.	0
1107	Given the anti-inflammatory role of @COMPOUND$ (RSV), we hypothesized that RSV would attenuate inflammation and @PROTEIN$ resistance caused by 10,12 CLA in human adipocytes.	1
1108	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1109	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1110	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1111	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1112	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1113	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1114	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1115	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1116	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1117	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1118	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1119	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1120	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1121	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1122	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with omapatrilat and @COMPOUND$ contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
1123	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with @COMPOUND$ and candesartan contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
1124	We recently reported @COMPOUND$ (Hcy)-induced @PROTEIN$-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	1
1125	We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to @COMPOUND$ and in Siglecs (Sia-recognizing Ig superfamily @PROTEIN$).	0
1126	Possible binding site for the substrate, prostaglandin H(2) (@COMPOUND$)), was identified by systematically probing the refined molecular structure of @PROTEIN$.	1
1127	Anti-P mAb promoted @PROTEIN$ overproduction in a dose- and time-dependent manner in both @COMPOUND$ (LPS)-activated RAW 264.7 cells and primary human macrophages.	0
1128	Increased secretion of hyperimmune antibodies following @COMPOUND$ stimulation of @PROTEIN$-activated human B cells in vitro.	1
1129	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: @PROTEIN$, lpa2 and lpa3.	1
1130	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, @PROTEIN$ and lpa3.	1
1131	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, lpa2 and @PROTEIN$.	1
1132	Some of the peptide derivatives inhibited @PROTEIN$-mediated uptake of ((3)H) @COMPOUND$-Sar.	1
1133	PCFT/@PROTEIN$ could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of @COMPOUND$ and haem at the level of intestinal absorption.	1
1134	Association between serum retinol-binding @PROTEIN$ and small dense low-density lipoprotein @COMPOUND$ levels in young adult women.	1
1135	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine @PROTEIN$ (@COMPOUND$-BSA).	1
1136	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine serum albumin (@COMPOUND$-@PROTEIN$).	1
1137	Role of @PROTEIN$ and Nox2 in hyperoxia-induced reactive @COMPOUND$ species generation and migration of human lung endothelial cells.	1
1138	Downregulation of @PROTEIN$, or pretreatment with @COMPOUND$, attenuated hyperoxia-induced cell migration and capillary tube formation, suggesting that ROS generated by Nox4 regulate endothelial cell motility.	0
1139	The study aim was to determine whether urine albumin/@COMPOUND$ ratio (UACR), high-sensitivity C-reactive protein (hsCRP) or N-terminal pro-@PROTEIN$ (Nt-proBNP) added to risk prediction based on HeartScore and history of diabetes or cardiovascular disease.	0
1140	@COMPOUND$ concentration in the liver and in plasma alanine aminotransferase (ALT) and aspartate transaminase (@PROTEIN$) activities were determined.	1
1141	In brain tissue, Cu concentration, superoxide dismutase (@PROTEIN$) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0
1142	In brain tissue, Cu concentration, @PROTEIN$ (SOD) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0
1143	In brain tissue, @COMPOUND$ concentration, @PROTEIN$ (SOD) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0
1144	In brain tissue, @COMPOUND$ concentration, superoxide dismutase (@PROTEIN$) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0
1145	Elevated amounts of @PROTEIN$, one of the @COMPOUND$-generating reactions of glycolysis, in wood frog brain during freezing would enhance the glycolytic capacity of the organ and support the maintenance of cellular energetics under the ischemic conditions of the frozen state.	1
1146	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and nitric oxide (NO).	1
1147	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and @COMPOUND$ (NO).	0
1148	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
1149	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
1150	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and nitric oxide (NO).	1
1151	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and nitric oxide (NO).	1
1152	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and @COMPOUND$ (NO).	0
1153	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and nitric oxide (NO).	1
1154	We therefore hypothesized that a diffusible product of the @PROTEIN$ enzyme reaction (possibly DAG (@COMPOUND$)) mediated the biological effects of the protein.	1
1155	The mitochondrial membrane potential (Delta psi (mit)) was also tested with @COMPOUND$ 30 min after SI challenge, and was shown to have collapsed in the incompatible pollen tubes after exposure to @PROTEIN$.	1
1156	In conclusion, female rats undernourished in utero had normophagic obesity as adults but had an absence of @COMPOUND$-induced hypophagia and low hypothalamic levels of the @PROTEIN$ receptor.	0
1157	Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of @COMPOUND$ in response to a meal allied to up-regulated hypothalamic @PROTEIN$ and transporter expression.	1
1158	They potentiate @COMPOUND$-induced @PROTEIN$ secretion and may be responsible for up to 70% of postprandial insulin secretion.	1
1159	However, in supraphysiological doses, @PROTEIN$ administration may completely normalize beta as well as alpha cell sensitivity to @COMPOUND$.	1
1160	Interaction of @COMPOUND$ with bovine @PROTEIN$ : determination of the binding mechanism and binding site by spectroscopic methods.	1
1161	The interaction between @COMPOUND$ (MG) and bovine @PROTEIN$ (BSA) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	1
1162	The interaction between @COMPOUND$ (MG) and bovine serum albumin (@PROTEIN$) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	1
1163	The binding distance (r) between MG and the @COMPOUND$ residue of @PROTEIN$ was obtained to be 4.79 nm according to Förster theory of non-radioactive energy transfer.	1
1164	Unlike @COMPOUND$, Cystatin C (@PROTEIN$) is believed to be independent of body composition in both adults and children.	0
1165	Unlike @COMPOUND$, @PROTEIN$ C (CysC) is believed to be independent of body composition in both adults and children.	0
1166	@COMPOUND$ controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1167	Glucose controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking @COMPOUND$-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1168	Lung injury was assessed by measuring vascular permeability (via @COMPOUND$), edema, neutrophil infiltration (via myeloperoxidase (@PROTEIN$), and expression of proinflammatory cytokines.	0
1169	Regulation of muscle protein degradation, not synthesis, by dietary @COMPOUND$ in rats fed @PROTEIN$-deficient diet.	0
1170	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the @PROTEIN$ (NDRG1-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
1171	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the n-myc downstream-regulated gene 1 protein (@PROTEIN$-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
1172	Although G (Na) is negligible in hormone-deprived cells, these cells displayed basal @PROTEIN$ activity that was sensitive to @COMPOUND$, an inhibitor of 3-phosphatidylinositol phosphate kinase (PI3K).	1
1173	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (@COMPOUND$, fluconazole and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
1174	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, @COMPOUND$ and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
1175	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, fluconazole and @COMPOUND$) by the reference method of the Clinical and Laboratory Standards Institute.	0
1176	The @COMPOUND$/@PROTEIN$ (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.	1
1177	Epigenetic reprogramming of breast cancer cells by @COMPOUND$ occurs regardless of @PROTEIN$ status.	0
1178	In the present study, we have investigated the effect of @PROTEIN$ on ABCA1 expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	1
1179	In the present study, we have investigated the effect of IFN-gamma on @PROTEIN$ expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	0
1180	As such, the aim of the present study was to investigate whether @PROTEIN$-inhibition with @COMPOUND$, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.	1
1181	In this review we discuss the @PROTEIN$ that transport arsenic and @COMPOUND$ into cells, from bacteria to humans, as well as some of the efflux proteins involved in detoxification.	1
1182	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with @COMPOUND$ or ferrous ions or by exposure to auto-oxidation products of arachidonic acid for 16h, and @PROTEIN$ was then assayed in medium.	0
1183	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with copper or ferrous ions or by exposure to auto-oxidation products of @COMPOUND$ for 16h, and @PROTEIN$ was then assayed in medium.	0
1184	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with copper or @COMPOUND$ or by exposure to auto-oxidation products of arachidonic acid for 16h, and @PROTEIN$ was then assayed in medium.	0
1185	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal @PROTEIN$ precursors, GAD67, cytochrome oxidase subunit I) by quantitative in situ hybridization histochemistry.	1
1186	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal neuropeptide precursors, GAD67, @PROTEIN$) by quantitative in situ hybridization histochemistry.	1
1187	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal neuropeptide precursors, @PROTEIN$, cytochrome oxidase subunit I) by quantitative in situ hybridization histochemistry.	1
1188	These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of @PROTEIN$ (SOD).	1
1189	These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of superoxide dismutase (@PROTEIN$).	1
1190	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (@PROTEIN$) and ATG12 proteins to their respective targets, @COMPOUND$ and the ATG5 protein.	1
1191	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (ATG8) and @PROTEIN$ proteins to their respective targets, @COMPOUND$ and the ATG5 protein.	1
1192	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (ATG8) and ATG12 proteins to their respective targets, @COMPOUND$ and the @PROTEIN$ protein.	0
1193	Levels of Atg transcripts and/or the @PROTEIN$-@COMPOUND$ adduct increase during leaf senescence and nitrogen and fixed-carbon limitations, indicating that autophagy plays a key role in nutrient remobilization.	1
1194	Promoter analysis of the @PROTEIN$, 4, and 11 genes in HeLa cells did not reveal a cis-regulatory element responsive to @COMPOUND$ in their 5'-flanking sequences.	0
1195	Pre-gravid physical activity and reduced risk of @COMPOUND$ intolerance in pregnancy : the role of @PROTEIN$ sensitivity.	1
1196	Thus, we sought to study the relationships between types of pre-gravid physical activity and metabolic parameters in pregnancy, including @COMPOUND$ tolerance, @PROTEIN$ sensitivity and beta-cell function.	0
1197	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of @PROTEIN$-II, Beclin-1, BAG-1 and cardioprotection.	1
1198	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, Beclin-1, @PROTEIN$ and cardioprotection.	1
1199	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, @PROTEIN$, BAG-1 and cardioprotection.	1
1200	Efficacy, safety and patient-reported outcomes of combination @PROTEIN$ and @COMPOUND$ versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.	0
1201	To determine the efficacy and safety of @PROTEIN$ and etanercept plus @COMPOUND$ versus sulfasalazine in patients with rheumatoid arthritis (RA) despite sulfasalazine therapy.	0
1202	Aberrant methylation of the @PROTEIN$ (O6-methylguanine-DNA methyltransferase) DNA-repair gene is a predictive marker for the response to chemotherapy with alkylating agents (e.g., @COMPOUND$) in malignant gliomas.	1
1203	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
1204	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
1205	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
1206	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
1207	Our results suggest a more prominent role for H2 as electron carrier in the syntrophic conversion of @COMPOUND$, when the essential trace metals W and Mo for the functioning of @PROTEIN$ are depleted.	1
1208	Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (@PROTEIN$) and response to @COMPOUND$ treatment.	1
1209	Effects of exhaustion and calcium supplementation on @PROTEIN$ and @COMPOUND$ levels in athletes.	0
1210	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on @COMPOUND$ and @PROTEIN$ levels in athletes at rest and exhaustion.	0
1211	One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0
1212	In contrast, chelating intracellular calcium ((Ca(2+))(i)) by @COMPOUND$ abolished @PROTEIN$-mediated Arc up-regulation.	0
1213	In contrast, chelating intracellular calcium ((@COMPOUND$+))(i)) by BAPTA-AM abolished @PROTEIN$-mediated Arc up-regulation.	0
1214	These data suggested novel functions of (@COMPOUND$+))(i) and CaM in @PROTEIN$ signaling.	1
1215	These data suggested novel functions of (@COMPOUND$+))(i) and @PROTEIN$ in BDNF signaling.	0
1216	Comparison of the Arc transcription profiles between @COMPOUND$+)-stimulated and @PROTEIN$-stimulated neurons demonstrated that the regulatory mechanisms were distinctively tailored to the complex features of neuronal activity.	0
1217	Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene.	1
1218	to describe a family with later onset congenital central hypoventilation syndrome (LO-CCHS) and heterozygosity for a 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene, rendered phenotypically apparent with exposure to anesthetics.	1
1219	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/@PROTEIN$ signalling.	0
1220	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of @PROTEIN$/STAT3 signalling.	0
1221	High @COMPOUND$ attenuates @PROTEIN$ expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.	1
1222	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
1223	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
1224	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
1225	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
1226	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
1227	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
1228	However, there are conflicting data regarding the role of Gpr30 as an @PROTEIN$ (ER): several laboratories were unable to demonstrate @COMPOUND$ binding to GPR30 or estradiol-activated signal transduction in Gpr30-expressing cells.	0
1229	Our data demonstrate that in vivo @PROTEIN$ is dispensable for the mediation of @COMPOUND$ effects in reproductive organs.	0
1230	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
1231	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
1232	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
1233	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
1234	Circulating oxidized LDL (oxLDL) levels are strongly correlated to LDL-@COMPOUND$ (LDL-c) and apolipoprotein-B100 (@PROTEIN$), making it difficult to disentangle their independent contributions to cardiovascular risk.	0
1235	FMD of the brachial artery and plasma concentrations of oxLDL, LDL-@COMPOUND$, and @PROTEIN$ were measured in 624 men and women (age range 50 to 87 years), participating in a population-based cohort study.	0
1236	After adjustment for age, sex, @COMPOUND$ tolerance status, and Framingham risk score, the oxLDL/@PROTEIN$ ratio was negatively related to FMD (P = 0.017).	0
1237	A single @COMPOUND$ insertion/deletion (4G/5G) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
1238	A single guanosine insertion/deletion (4G/@COMPOUND$) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
1239	Influence of @PROTEIN$ on buffalo (Bubalus bubalis) spermatozoa motility, membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	0
1240	The objective of the present experiment was to examine the influence of mean physiological concentration of insulin-like growth factor-I (@PROTEIN$) on frozen-thawed Surti buffalo (Bubalus bubalis) spermatozoa functional parameters, i.e., motility, plasmalemma integrity, acrosomal integrity, functional membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	1
1241	Frozen-thawed semen samples (n=6) were washed in @COMPOUND$ and divided into two equal parts (control and @PROTEIN$ groups).	0
1242	@COMPOUND$ utilization was significantly higher in @PROTEIN$ 0.01) of incubation.	0
1243	Signaling involving @COMPOUND$ is organized in subcellular compartments and a distinct cAMP compartment might be required for proper @PROTEIN$ mobility and function.	1
1244	We also found an inhibitory effect of @COMPOUND$ on the associations between cadherin 5, @PROTEIN$ and CD31, adherens junction proteins whose interaction is critical for endothelial cell cord formation.	1
1245	We also found a strong inhibitory effect of @COMPOUND$ on hypoxia-induced endothelial cell formation of cords and @PROTEIN$ expression, the main mediator of hypoxia-mediated effects and a key driver of angiogenesis and metastasis.	1
1246	Control @COMPOUND$-loaded @PROTEIN$ nanoparticles with IgG2a antibodies yielded only marginal effects.	1
1247	@PROTEIN$ secretion is highly sensitive to desorption of plasma membrane @COMPOUND$.	1
1248	Suppression of retinal @PROTEIN$ in experimental diabetes and @COMPOUND$-induced retinopathy: role of NADPH oxidase.	0
1249	The increase of @COMPOUND$ availability caused the induction of the antioxidant enzyme @PROTEIN$, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	1
1250	In the present study, the mRNA expression and promoter @COMPOUND$ methylation of @PROTEIN$ isoforms (i.e.	0
1251	The present study is the first report that demonstrates selective inactivation of @PROTEIN$ isoforms through the promoter @COMPOUND$ methylation pathway in leukaemias.	1
1252	@PROTEIN$ monogalactosyldiacylglycerol synthases are involved in @COMPOUND$ starvation-induced lipid remodeling, and are crucial for low-phosphate adaptation.	1
1253	Expression levels of the functional activities (albumin secretion and @COMPOUND$ removal) and the cell-cell adhesion molecules (cadherin and @PROTEIN$) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.	0
1254	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0
1255	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0
1256	Angiotensin II (@PROTEIN$) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1257	Angiotensin II (Ang II) is the key @PROTEIN$ in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1258	Angiotensin II (Ang II) is the key peptide hormone in the renin-@PROTEIN$-@COMPOUND$ system (RAAS).	1
1259	@PROTEIN$ (Ang II) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1260	The enzyme responsible for D-@COMPOUND$ biosynthesis, @PROTEIN$ (SR), is therefore a promising target for treatment of neuropathologies related to glutamate receptor excitotoxicity, such as stroke or Alzheimer's disease.	1
1261	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with @COMPOUND$, or toluidine blue staining.	0
1262	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with propidium iodide, or @COMPOUND$ staining.	0
1263	To investigate the metabolism of @COMPOUND$ through the @PROTEIN$ (CYP450) metabolic pathway, we studied the in vitro rat liver microsomal production of hydroxylated metabolites and their activity at recombinant human TRPV(1) receptors.	1
1264	Functional expression of @PROTEIN$ responsible for protection against oxidative stress through promotion of @COMPOUND$ synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	1
1265	Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of @COMPOUND$ synthesis after @PROTEIN$ upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	0
1266	Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (@PROTEIN$) on serine133 and CRE reporter activity in a manner sensitive to @COMPOUND$, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of hydrogen peroxide, but not of either 2,4-dinitirophenol or tunicamycin.	1
1267	Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (@PROTEIN$) on serine133 and CRE reporter activity in a manner sensitive to propranolol, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of @COMPOUND$, but not of either 2,4-dinitirophenol or tunicamycin.	1
1268	These results suggest that adrenaline may selectively protect mesenchymal C3H10T1/2 cells from oxidative stress through a mechanism related to the promoted biosynthesis of @COMPOUND$ in association with transient @PROTEIN$ expression after activation of beta(2)AdR.	1
1269	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
1270	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human @PROTEIN$ (HSA) using various biophysical methods.	1
1271	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human @PROTEIN$ (HSA) using various biophysical methods.	1
1272	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
1273	The observed fluorescence quenching of @PROTEIN$ by @COMPOUND$ is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	1
1274	From the observed Förster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in @PROTEIN$) to acceptor (@COMPOUND$) distance is calculated to be 3.2 nm.	1
1275	The preferred binding site of IOC was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and @COMPOUND$-bound @PROTEIN$.	1
1276	The preferred binding site of IOC was analyzed by ligand displacement experiments with @COMPOUND$ (ANS) and warfarin-bound @PROTEIN$.	1
1277	The preferred binding site of @COMPOUND$ was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and warfarin-bound @PROTEIN$.	1
1278	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a GOD (@PROTEIN$) amperometric biosensor is employed for the glucose determination.	0
1279	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a @PROTEIN$ (glucose oxidase) amperometric biosensor is employed for the glucose determination.	1
1280	Furthermore, constitutive expression of an @COMPOUND$-insensitive, active form of @PROTEIN$ protein mimicked the effects of low oxygen, inhibiting the differentiation of trophoblast giant cells.	0
1281	It has been proposed that there is improvement in @COMPOUND$ and @PROTEIN$ metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.	0
1282	A study of rituximab and ifosfamide, carboplatin, and @COMPOUND$ chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
1283	A study of rituximab and ifosfamide, @COMPOUND$, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
1284	A study of rituximab and @COMPOUND$, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
1285	The expressions of serotonin receptors (5-hydroxytryptamine receptor), corticotropin-releasing hormone (@PROTEIN$) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1286	The expressions of serotonin receptors (5-hydroxytryptamine receptor), @PROTEIN$ (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1287	The expressions of serotonin receptors (@PROTEIN$), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1288	The expressions of @PROTEIN$ (5-hydroxytryptamine receptor), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1289	Total plasma @COMPOUND$ level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and cobalamin levels were determined.	0
1290	Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and @COMPOUND$ levels were determined.	0
1291	Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma @COMPOUND$ and cobalamin levels were determined.	0
1292	This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for @COMPOUND$ signaling and the control of epithelial @PROTEIN$-alpha (ENaCalpha) subunit gene expression in the collecting duct.	0
1293	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the @PROTEIN$ (CEA) promoter.	1
1294	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
1295	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
1296	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the @PROTEIN$ (CEA) promoter.	1
1297	Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by CEA promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific @PROTEIN$ promoter) with @COMPOUND$ administration were examined in several GBC lines and normal cells.	0
1298	Cyclophilin A (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (@PROTEIN$) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	0
1299	Cyclophilin A (@PROTEIN$), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1
1300	@PROTEIN$ (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1
1301	Augmentation of antibody responses by @COMPOUND$ and @PROTEIN$.	0
1302	Therefore, we queried whether @COMPOUND$ is prosurvival in podocytes through a @PROTEIN$-dependent pathway.	0
1303	Treatment with pioglitazone, associated with @COMPOUND$, showed a reduction of @PROTEIN$ monocyte production after their in vitro activation with LPS.	1
1304	Regulation of T-type @PROTEIN$.1 channels expression by synthetic glucocorticoid @COMPOUND$ in neonatal cardiac myocytes.	1
1305	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated beta-glucosidases (beta-@PROTEIN$) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
1306	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated @PROTEIN$ (beta-Glu) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
1307	Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor @COMPOUND$ through @PROTEIN$ translocation.	1
1308	@COMPOUND$ converted unconjugated @PROTEIN$ (LC3-I) to conjugated light chain 3 (LC3-II) and induced localization of LC3 to autophagosomes.	1
1309	@COMPOUND$ converted unconjugated microtubule-associated protein light chain 3 (@PROTEIN$) to conjugated light chain 3 (LC3-II) and induced localization of LC3 to autophagosomes.	1
1310	@COMPOUND$ converted unconjugated microtubule-associated protein light chain 3 (LC3-I) to conjugated light chain 3 (@PROTEIN$) and induced localization of LC3 to autophagosomes.	1
1311	@COMPOUND$ converted unconjugated microtubule-associated protein light chain 3 (LC3-I) to conjugated light chain 3 (LC3-II) and induced localization of @PROTEIN$ to autophagosomes.	1
1312	@PROTEIN$ (AIF), which plays a role in caspase-independent cell death, translocated to the nucleus in response to @COMPOUND$ treatment.	1
1313	Apoptosis inducing factor (@PROTEIN$), which plays a role in caspase-independent cell death, translocated to the nucleus in response to @COMPOUND$ treatment.	1
1314	Inhibition of @PROTEIN$ by @COMPOUND$ analogues: Implications for anticancer activity.	1
1315	@PROTEIN$-@COMPOUND$ (HDL-C) is invertedly related to the incidence of cardiovascular events.	1
1316	An isocratic fluorescence HPLC assay for the monitoring of @PROTEIN$ activity and l-@COMPOUND$ depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.	0
1317	Anti-gastric cancer effects of @COMPOUND$, a selective COX-2 inhibitor, through inhibition of @PROTEIN$ signaling.	1
1318	Among the R-Nx strains, a substitution of @COMPOUND$ to Cys at position 81 (Gly81à Cys) of the @PROTEIN$ gene in 10 strains isolated from wild birds and ovine foetuses, and of Asp to Tyr at position 87 (Asp87à Tyr) in one strain isolated from ewe faeces, were revealed by sequencing the gene.	1
1319	Emerging evidence that both @PROTEIN$ (BDNF) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
1320	Emerging evidence that both brain-derived neurotrophic factor (@PROTEIN$) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
1321	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1322	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1323	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1324	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1325	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1326	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1327	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1328	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1329	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
1330	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
1331	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
1332	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
1333	@PROTEIN$, vascular endothelial growth factor, and @COMPOUND$ increased EC permeability, disrupted cell junctions, and induced stress fiber formation.	0
1334	Uptake of @COMPOUND$, losartan, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
1335	Uptake of valsartan, @COMPOUND$, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
1336	Uptake of valsartan, losartan, and @COMPOUND$ was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
1337	In contrast to cefadroxil, no @PROTEIN$-specific uptake of @COMPOUND$ and losartan was found.	0
1338	In contrast to cefadroxil, no @PROTEIN$-specific uptake of valsartan and @COMPOUND$ was found.	0
1339	In contrast to @COMPOUND$, no @PROTEIN$-specific uptake of valsartan and losartan was found.	1
1340	@COMPOUND$ plus single-dose @PROTEIN$ glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.	0
1341	Among them, @COMPOUND$ and 5 had significant @PROTEIN$ inhibitory activities.	1
1342	In vitro effects of @COMPOUND$ treatment on fish liver @PROTEIN$ activity.	1
1343	The effect of @COMPOUND$ (PN), a highly toxic agent, on @PROTEIN$ (CAT) activity in fish liver microsomal homogenates was determined.	1
1344	The effect of @COMPOUND$ (PN), a highly toxic agent, on catalase (@PROTEIN$) activity in fish liver microsomal homogenates was determined.	1
1345	Reduced responses of alpha-MSH or @PROTEIN$-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
1346	Reduced responses of alpha-MSH or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type @PROTEIN$ system in nonsurvivors.	0
1347	Reduced responses of alpha-MSH or Nac-beta-END IRM to @PROTEIN$ and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
1348	Reduced responses of @PROTEIN$ or Nac-beta-END IRM to CRH and the invalid suppression by @COMPOUND$ reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.	0
1349	Toll-like receptor (@PROTEIN$) 4 is a critical receptor and signal transducer for @COMPOUND$ (LPS), a major component of Gram-negative bacteria.	1
1350	Postprandial @COMPOUND$ and @PROTEIN$.05) in HTAG.	0
1351	Increased intrahepatic vascular tone in cirrhosis has been attributed to a decrease of hepatic @COMPOUND$ (NO) secondary to disturbances in the post-translational regulation of the enzyme @PROTEIN$.	0
1352	QSAR studies for the inhibition of the transmembrane @PROTEIN$ isozyme XIV with @COMPOUND$ using PRECLAV software.	1
1353	QSAR studies for the inhibition of isozyme XIV of human @PROTEIN$ (CA, EC 4.2.1.1) by a series of @COMPOUND$ including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.	1
1354	Inhibitory effects of Cefazolin and @COMPOUND$ on the activity of mushroom @PROTEIN$.	1
1355	Inhibitory effects of @COMPOUND$ and Cefodizime on the activity of mushroom @PROTEIN$.	1
1356	The order of the cytotoxicity of the compounds was; IV &gt; III &gt; II &gt; I &gt; V. @COMPOUND$, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest @PROTEIN$ inhibition.	1
1357	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0
1358	Hepatic antioxidant status viz, @COMPOUND$ (GSH), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1359	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1360	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1361	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0
1362	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0
1363	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1364	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0
1365	Preliminary structure-activity relationships and a molecular modeling study for 9a have revealed that the @COMPOUND$ moiety plays a key role in the interaction of this series of derivatives with @PROTEIN$ by acting as an anchor in its peripheral anionic site.	1
1366	Heme oxygenase-1 (@PROTEIN$) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
1367	@PROTEIN$ (HO-1) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
1368	One potential target for reducing T cell migration is inhibition of the @COMPOUND$+)-activated neutral protease @PROTEIN$.	1
1369	One potential target for reducing T cell migration is inhibition of the @COMPOUND$+)-activated @PROTEIN$ calpain.	0
1370	@COMPOUND$, a newer anticonvulsant, does not undergo @PROTEIN$ metabolism and does not alter the pharmacokinetics of chemotherapy, antiemetics, and corticosteroids, which are metabolized by the liver.	0
1371	The main mechanism of resistance to @COMPOUND$ was extra-chromosomal amplification of the @PROTEIN$ gene.	1
1372	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) @COMPOUND$ (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
1373	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by @COMPOUND$ (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
1374	The @COMPOUND$-enhanced degradation of @PROTEIN$ involves both proteasomal and lysosomal activities.	1
1375	As this effect might be related to deregulation of @PROTEIN$ (Cx43) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
1376	As this effect might be related to deregulation of connexin 43 (@PROTEIN$) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
1377	Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total @PROTEIN$ protein levels, thus suggesting that both proteasomes and lysosomes may participate in the @COMPOUND$-enhanced Cx43 internalization and degradation.	1
1378	Finally, @COMPOUND$ also interfered with restoration of gap junction plaques following the inhibition of @PROTEIN$ transport to plasma membrane.	1
1379	Taken together, multiple modes of action seem to contribute to downregulation of @PROTEIN$ in @COMPOUND$-treated rat liver epithelial cells.	1
1380	@PROTEIN$ has been identified as an endoplasmic reticulum (ER)-resident @COMPOUND$+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.	1
1381	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, @COMPOUND$ (E) and lysine (K), at the solvent accessible site of @PROTEIN$.	1
1382	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, glutamic acid (E) and @COMPOUND$ (K), at the solvent accessible site of @PROTEIN$.	1
1383	Cloning, expression, and characterization of @COMPOUND$-induced @PROTEIN$ from the earthworms Metaphire posthuma and Polypheretima elongata.	1
1384	In this study we report the sequences of @PROTEIN$ cDNA from two species of Megascoleidae earthworms, Metaphire posthuma and Polypheretima elongata, by mRNA differential display after exposure of the organisms to @COMPOUND$.	1
1385	Complementary (c)DNA was verified as the @PROTEIN$ gene by the characteristics of its predicted translation product, namely a high @COMPOUND$ content, conserved CXC motifs, and a molecular weight of around 8 kDa.	1
1386	These earthworms could be used to evaluate heavy-metal pollution in soil due to the inducible @PROTEIN$ by @COMPOUND$ exposure.	1
1387	The most active compound to emerge from the in vitro and in vivo murine studies was 2b, suggesting an antimalarial activity via inhibition of @PROTEIN$ hydrolysis, however, not as efficient as @COMPOUND$.	0
1388	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in uracil or @COMPOUND$, cause substantial reductions in XDG and @PROTEIN$ activities.	0
1389	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl @COMPOUND$ in uracil or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
1390	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in @COMPOUND$ or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
1391	Most interestingly, a proline substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1392	Most interestingly, a proline substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1393	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1394	Most interestingly, a proline substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1395	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1396	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1397	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of glutamate dehydrogenase (@PROTEIN$).	1
1398	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of @PROTEIN$ (GDH).	1
1399	Functional inactivation of @PROTEIN$/@COMPOUND$ in human mesothelioma.	0
1400	The tumor suppressor @COMPOUND$ is encoded by the neurofibromatosis type 2 gene (@PROTEIN$) which is located on chromosome 22q12 and mutations in this gene have been found in 40% of mesothelioma.	1
1401	No main effect of group assignment on TSST responses was found for @PROTEIN$, @COMPOUND$ or POMS scores.	0
1402	@COMPOUND$-induced expression of the orphan nuclear receptor @PROTEIN$ in MA-10 Leydig cells involves a CaMKI pathway.	1
1403	@COMPOUND$-induced expression of the orphan nuclear receptor Nur77 in MA-10 Leydig cells involves a @PROTEIN$ pathway.	1
1404	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/@COMPOUND$ (cAMP) signaling pathway.	1
1405	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/cyclic adenosine monophosphate (@COMPOUND$) signaling pathway.	1
1406	Here, we report that @COMPOUND$-mediated induction of @PROTEIN$ expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.	1
1407	In addition, our detailed analysis of the @PROTEIN$ promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and @COMPOUND$-induced Nur77 transcription.	1
1408	Comparing expression of @COMPOUND$ and @PROTEIN$ in testicular tissue from men with obstructive and nonobstructive azoospermia.	0
1409	Here we present evidence of distinct @COMPOUND$-induced modulation of @PROTEIN$ functions using high-resolution live-cell imaging approaches.	1
1410	Quantitative analysis yielded 0.81 and 1.8 microM for EC(50) values of @COMPOUND$-induced cell edge translocation of abl-KD-@PROTEIN$ (GFP) and wild-type abl-GFP, respectively.	1
1411	Association of the @PROTEIN$ gene polymorphisms 2677G&gt;T/A and 3435C&gt;T with clinical outcomes of @COMPOUND$ monotherapy in metastatic breast cancer patients.	1
1412	We evaluated the association between clinical outcome (safety and efficacy) of @COMPOUND$ monotherapy in metastatic breast cancer patients with @PROTEIN$ gene polymorphisms 2677G&gt;T/A or 3435C&gt;T.	1
1413	This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (@PROTEIN$) inhibitor @COMPOUND$ or pharmacological inhibition of PKB.	1
1414	This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (PI3K) inhibitor @COMPOUND$ or pharmacological inhibition of @PROTEIN$.	0
1415	@COMPOUND$ (KYNA) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
1416	Kynurenic acid (@COMPOUND$) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
1417	Molecular dynamics simulation techniques have been used to study the unbinding pathways of @COMPOUND$) from the ligand-binding pocket of the vitamin D receptor (@PROTEIN$).	1
1418	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1419	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1420	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1421	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1422	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1423	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1424	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1425	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1426	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1427	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1428	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1429	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1430	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1431	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1432	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1433	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1434	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1435	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1436	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1437	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1438	It controls the expression of a total of 11 genes, the @PROTEIN$ regulon, in a @COMPOUND$-dependent manner.	1
1439	We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis @PROTEIN$ gene during the development of @COMPOUND$ (RIF) resistance using an electrochemical genosensor.	1
1440	In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both codeine and @COMPOUND$ O-demethylation.	1
1441	In contrast, @PROTEIN$.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both @COMPOUND$ and dextromethorphan O-demethylation.	1
1442	@PROTEIN$ activity was evaluated by measuring @COMPOUND$+) entry or pore formation using spectrofluorometry or flow cytometry.	1
1443	At the end of treatment, BMI, WHR, HbA1c, fasting @COMPOUND$, @PROTEIN$, HOMA-IR, alanine aminotransferase values decreased in both groups.	0
1444	The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, @PROTEIN$ (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
1445	The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, adrenocorticotropic hormone (ACTH), gonadotropic hormone, @PROTEIN$, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
1446	The anterior pituitary gland contains five types of cells secreting specific hormones (@PROTEIN$, adrenocorticotropic hormone (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
1447	We examined the relationship between @PROTEIN$ and serum calcium, @COMPOUND$, 1,25(OH)(2)D(3), and PTH levels in haemodialysis patients.	0
1448	Intracellular @COMPOUND$ (-) is required for the motor function of @PROTEIN$, a unique plasma membrane molecular motor of these cells.	1
1449	Light stimulates @COMPOUND$ hydrolysis via the G-protein @PROTEIN$, which directly binds to and activates phosphodiesterase.	1
1450	We injected females with human chorionic gonadotropin (@PROTEIN$), estradiol, estradiol plus progesterone, saline, or HCG plus @COMPOUND$ (an aromatase blocker) and tested their responses to mating calls.	0
1451	We injected females with human chorionic gonadotropin (@PROTEIN$), @COMPOUND$, estradiol plus progesterone, saline, or HCG plus fadrozole (an aromatase blocker) and tested their responses to mating calls.	0
1452	We injected females with human chorionic gonadotropin (@PROTEIN$), estradiol, estradiol plus @COMPOUND$, saline, or HCG plus fadrozole (an aromatase blocker) and tested their responses to mating calls.	0
1453	@PROTEIN$ is a polypeptide hormone that is present in mammals and its main function is the maintenance of adequate @COMPOUND$ level.	1
1454	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous insulin injection implicating @PROTEIN$ as the primary cause of the observed hypocortisolism.	1
1455	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous @PROTEIN$ injection implicating CYP17 as the primary cause of the observed hypocortisolism.	1
1456	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as methylenetetrahydrofolate reductase (@PROTEIN$).	1
1457	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as @PROTEIN$ (MTHFR).	1
1458	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
1459	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	1
1460	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
1461	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
1462	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
1463	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
1464	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
1465	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
1466	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
1467	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
1468	Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz(a) @COMPOUND$ (DMBA), Tg(MMTV-Neu)202Mul/J (@PROTEIN$), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	0
1469	Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz(a) anthracene (@COMPOUND$), Tg(MMTV-Neu)202Mul/J (@PROTEIN$), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	0
1470	@PROTEIN$ kinase inhibition by @COMPOUND$ ameliorates diabetes-induced microvascular damage.	1
1471	Involvement of the @PROTEIN$/Rho kinase (ROCK) pathway in diabetic microvasculopathy and therapeutic potential of @COMPOUND$, a selective ROCK inhibitor, are investigated.	1
1472	The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-superoxide dismutase and @PROTEIN$ activities, O (2) (*-) production, lipid peroxidation, and @COMPOUND$ levels.	0
1473	The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-@PROTEIN$ and catalase activities, O (2) (*-) production, lipid peroxidation, and @COMPOUND$ levels.	0
1474	This decrease was not modified by @PROTEIN$ or @COMPOUND$, demonstrating that ONOO (-) was responsible for the effect.	0
1475	This decrease was not modified by @PROTEIN$ or Trolox, demonstrating that @COMPOUND$ (-) was responsible for the effect.	0
1476	A low plasma @PROTEIN$ @COMPOUND$ (HDL-c) concentration is an important risk factor for the development of atherosclerotic cardiovascular disease.	1
1477	The cancer cells could find an alternate pathway to make this protein that does not require @COMPOUND$ secretion, or the cancer cells may actually utilize progesterone and thus make @PROTEIN$ in a similar fashion to normal pregnancy.	0
1478	Decreased oral absorption of @COMPOUND$ after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-@PROTEIN$ to the first-pass metabolism in intestinal epithelial cells.	0
1479	Each residue was modified with one to three @COMPOUND$ units, and the most dominant @PROTEIN$ glycoform was modified with nine hexose units.	1
1480	The relationships among obesity, metabolic syndrome, ED, sex hormone-binding globulin (@PROTEIN$) and serum total and free @COMPOUND$ levels are complex and often confusing to the physician.	1
1481	In order to further analyse the protective mode of action, the superoxide anion scavenging activity of two extracts was evaluated in a @COMPOUND$/@PROTEIN$ system.	1
1482	In order to further analyse the protective mode of action, the @COMPOUND$ anion scavenging activity of two extracts was evaluated in a xanthine/@PROTEIN$ system.	0
1483	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (@PROTEIN$, catalase, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
1484	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and @COMPOUND$).	0
1485	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
1486	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, @PROTEIN$, glutathione-S-transferase and @COMPOUND$).	0
1487	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and @COMPOUND$ as well as hydrogen peroxide and ammonia.	1
1488	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as @COMPOUND$ and ammonia.	1
1489	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as hydrogen peroxide and @COMPOUND$.	1
1490	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as @COMPOUND$ and methylglyoxal as well as hydrogen peroxide and ammonia.	1
1491	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as @COMPOUND$ and ammonia.	1
1492	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as @COMPOUND$ and methylglyoxal as well as hydrogen peroxide and ammonia.	1
1493	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and @COMPOUND$ as well as hydrogen peroxide and ammonia.	1
1494	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as hydrogen peroxide and @COMPOUND$.	1
1495	Experiments using a classical inhibitor of phosphotyrosine @PROTEIN$, @COMPOUND$, also showed that the ecto-phosphatase activity was inhibited in a dose-dependent manner.	1
1496	Both promoters are partially regulated by @COMPOUND$ via @PROTEIN$ and other RARs.	1
1497	Circulating @COMPOUND$, adiponectin, leptin, @PROTEIN$, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
1498	Circulating @COMPOUND$, adiponectin, leptin, TNF-alpha, hsCRP and @PROTEIN$ levels were determined both at baseline and after TLC intervention and statin treatment.	0
1499	Circulating @COMPOUND$, adiponectin, @PROTEIN$, TNF-alpha, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
1500	Currently, adreno-corticotrophic hormone (@PROTEIN$), steroids and @COMPOUND$ (VGB) form the mainstay of its treatment.	0
1501	The addition of a protein kinase C (PKC) activator, @COMPOUND$, rescued PhIP-inhibited @PROTEIN$ expression in LTA-stimulated cells.	1
1502	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, @PROTEIN$, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
1503	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, @PROTEIN$ content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
1504	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, @PROTEIN$, and iNOS in pancreatic lymph nodes.	0
1505	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and @PROTEIN$ in pancreatic lymph nodes.	0
1506	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, @PROTEIN$, IL-17, and iNOS in pancreatic lymph nodes.	0
1507	They secreted @PROTEIN$ in response to @COMPOUND$ and could correct hyperglycemia in vivo when cotransplanted with vascular cells.	1
1508	This action was mimicked solely by 100 nm CH-275, a selective agonist at the somatostatin type 1 receptor (@PROTEIN$), but not by 100 nm BIM-23027, L-362855, or @COMPOUND$ ; agonists selective for the other four SSTRs known to exist in MIN6.	0
1509	The aim of this study was to assess in rats the effect of protein feeding on the: 1) distribution of endogenous @COMPOUND$ production (EGP) among gluconeogenic organs, and 2) repercussion on the @PROTEIN$ sensitivity of glucose metabolism.	1
1510	To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0
1511	To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator @COMPOUND$ acetoxymethyl ester.	0
1512	To test this hypothesis, we measured the effect of @PROTEIN$ on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0
1513	To test this hypothesis, we measured the effect of AMT on @PROTEIN$ channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 @COMPOUND$ ester.	0
1514	MIN6 cells excreted insulin, @PROTEIN$, @COMPOUND$ and ghrelin.	0
1515	MIN6 cells excreted insulin, glucagon, @COMPOUND$ and @PROTEIN$.	0
1516	They expressed mRNAs of insulin I and II, proglucagon, @COMPOUND$, @PROTEIN$ (PP) and ghrelin which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	0
1517	They expressed mRNAs of insulin I and II, proglucagon, @COMPOUND$, pancreatic polypeptide (PP) and @PROTEIN$ which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	0
1518	They expressed mRNAs of @PROTEIN$ I and II, proglucagon, @COMPOUND$, pancreatic polypeptide (PP) and ghrelin which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	0
1519	@PROTEIN$, @COMPOUND$ and ghrelin were detectable in the culture medium.	0
1520	Glucagon, @COMPOUND$ and @PROTEIN$ were detectable in the culture medium.	0
1521	@PROTEIN$ (MTs) are @COMPOUND$-rich, metal-binding proteins that are useful biomarkers for monitoring pollution by heavy metals.	1
1522	The deduced amino acid sequence has 18 @COMPOUND$ residues, implying that S. henanense @PROTEIN$ binds six equivalents of bivalent metal ions (Cd) as opposed to the seven in its mammalian counterparts.	1
1523	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, @PROTEIN$, @COMPOUND$, HbA1C, PTH, Mg and creatinine analysis.	0
1524	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, alkaline phosphatase, phosphorus, HbA1C, @PROTEIN$, Mg and @COMPOUND$ analysis.	0
1525	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, alkaline phosphatase, @COMPOUND$, HbA1C, @PROTEIN$, Mg and creatinine analysis.	0
1526	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, @PROTEIN$, phosphorus, HbA1C, PTH, Mg and @COMPOUND$ analysis.	0
1527	Association between @PROTEIN$ resistance, @COMPOUND$ intolerance, and hypertension in pregnancy.	0
1528	These results suggest that @PROTEIN$ resistance and relative @COMPOUND$ intolerance are associated with an increased risk of new-onset hypertension in pregnancy, particularly preeclampsia, and support the hypothesis that insulin resistance may play a role in the pathogenesis of this disorder.	0
1529	These @PROTEIN$ are likely to perform similar functions to those reported for other mammalian ADHs in the metabolism of ingested and endogenous @COMPOUND$ and aldehydes.	1
1530	Pretreatment with oligonol diminished the levels of proliferating cell nuclear antigen and expression of @PROTEIN$ in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
1531	Pretreatment with oligonol diminished the levels of @PROTEIN$ and expression of COX-2 in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
1532	TnBP (@COMPOUND$) and polysorbate 20 during the manufacture of the factor VIII/@PROTEIN$ concentrate Optivate has been investigated.	0
1533	We propose that the coordinated regulation of @PROTEIN$ cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to @COMPOUND$+)-induced axon growth inhibition.	1
1534	In this work we show that in FaO rat hepatoma cells inhibition of the @PROTEIN$ (EGFR) with the tyrphostin @COMPOUND$ enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	1
1535	In this work we show that in FaO rat hepatoma cells inhibition of the epidermal growth factor receptor (@PROTEIN$) with the tyrphostin @COMPOUND$ enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	1
1536	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (@PROTEIN$) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1537	@PROTEIN$, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1538	BDNF, NGF, @PROTEIN$ (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1539	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and @PROTEIN$ procedures.	0
1540	BDNF, @PROTEIN$, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1541	BDNF, NGF, adrenocorticotropic hormone (@PROTEIN$), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1542	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and @PROTEIN$ (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1543	Preprandial concentrations of glucose, @PROTEIN$, @COMPOUND$, and IGF-I fluctuated over time without significant treatment effect.	0
1544	Preprandial concentrations of @COMPOUND$, NEFA, lactate, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
1545	Preprandial concentrations of glucose, NEFA, @COMPOUND$, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
1546	Preprandial concentrations of @COMPOUND$, @PROTEIN$, lactate, and IGF-I fluctuated over time without significant treatment effect.	0
1547	In late gestation, the postprandial increases in @COMPOUND$ and @PROTEIN$ were delayed, and smaller, after a high-fiber meal than after a control meal.	0
1548	During lactation, @COMPOUND$ and @PROTEIN$ profiles after a standard meal did not differ between sows from treatment groups.	0
1549	Domain shape annealing is observed from branched to rounded shapes after @PROTEIN$ activity quenching by @COMPOUND$, with a decay halftime of approximately 10 min.	0
1550	Using neighborhood approaches, we were able to assign seven novel functional partners in @PROTEIN$ synthesis, @COMPOUND$ metabolism, and quorum sensing to BLUF domain-containing proteins (involved in light sensing).	0
1551	Chondroitin lyases (or @PROTEIN$) are a family of enzymes that depolymerize @COMPOUND$ (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	1
1552	@COMPOUND$ overcomes cell-adhesion-mediated drug resistance through downregulation of @PROTEIN$ expression in multiple myeloma.	1
1553	Drug-resistant cancer cells became sensitive to @COMPOUND$ treatment when @PROTEIN$ was expressed in cytosol.	1
1554	All the analyzed resistant mutants exhibited both increased @COMPOUND$ efflux and increased transcription of mmpS5-@PROTEIN$ genes, encoding a hypothetical efflux system belonging to the resistance-nodulation-division (RND) family of transporters.	0
1555	All the analyzed resistant mutants exhibited both increased @COMPOUND$ efflux and increased transcription of @PROTEIN$-mmpL5 genes, encoding a hypothetical efflux system belonging to the resistance-nodulation-division (RND) family of transporters.	0
1556	@COMPOUND$ and DHEA-sulfate response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
1557	Cortisol and @COMPOUND$ response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
1558	Cortisol and @COMPOUND$ response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
1559	@COMPOUND$ and DHEA-sulfate response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
1560	Treatment of RPE cells with high @COMPOUND$-induced a significant increased of @PROTEIN$, accompanied by an increase in cell damage, NO and nitrotyrosine levels.	1
1561	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of @PROTEIN$ expression that requires the activation of p38MAPK and ERK.	1
1562	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of p38MAPK and @PROTEIN$.	0
1563	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of @PROTEIN$ and ERK.	0
1564	@PROTEIN$ is involved in @COMPOUND$-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	1
1565	Both @PROTEIN$ and PKA are effectors of the second messenger @COMPOUND$.	1
1566	CYP719A subfamily of @PROTEIN$ oxygenases and @COMPOUND$ alkaloid biosynthesis in Eschscholzia californica.	0
1567	Radical scavenging activity of lipophilized products from @PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids.	1
1568	Lipase-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized @PROTEIN$ from Candida antarctica (E.C.	1
1569	@PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized lipase from Candida antarctica (E.C.	1
1570	This injury induces central sensitization leading to tactile allodynia and is mediated by activation of @COMPOUND$+) permeable AMPA/kainate receptors through @PROTEIN$ and PKA.	1
1571	Stimulation of choline @PROTEIN$ by @COMPOUND$, a neural cell adhesion molecule ligand.	1
1572	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces @PROTEIN$-stimulated PKB activation and @COMPOUND$ uptake.	0
1573	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces insulin-stimulated @PROTEIN$ activation and @COMPOUND$ uptake.	0
1574	This is the first @PROTEIN$ with a known primary structure and a glutamine instead of @COMPOUND$ residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
1575	This is the first @PROTEIN$ with a known primary structure and a @COMPOUND$ instead of glycine residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
1576	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood @COMPOUND$, or plasma concentrations of catecholamines, @PROTEIN$, and cortisol.	0
1577	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
1578	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
1579	Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the norepinephrine transporter (@PROTEIN$) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1
1580	Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the @PROTEIN$ (NET) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1
1581	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the @PROTEIN$ and SERT, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0
1582	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the NET and @PROTEIN$, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0
1583	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of @PROTEIN$ not of PP1.	1
1584	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of @PROTEIN$ not of PP1.	1
1585	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of PP2B not of @PROTEIN$.	0
1586	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of PP2B not of @PROTEIN$.	0
1587	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from genipin-crosslinked gelatin within @COMPOUND$ (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
1588	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from @COMPOUND$-crosslinked gelatin within polycaprolactone (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
1589	In this study, 10% (w/v) gelatin was mixed with @PROTEIN$, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) @COMPOUND$, and then sucked into the wall of PCL conduits.	0
1590	Effects of @PROTEIN$/ANKK1 gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
1591	Effects of DRD2/@PROTEIN$ gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
1592	The majority of patients with acute depression shows an exaggerated plasma corticotrophin (@PROTEIN$) and @COMPOUND$ response to this test that normalizes gradually during successful antidepressant therapy.	0
1593	We examined plasma @PROTEIN$ and @COMPOUND$ responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).	0
1594	However, the ethyl ester of commipheric acid (150 mg/kg, twice daily) lowered fasting blood @COMPOUND$ and plasma @PROTEIN$, and plasma triglycerides without affecting food intake or body weight.	0
1595	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (@PROTEIN$) and glutathione peroxidases (GPx).	1
1596	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (GST) and @PROTEIN$ (GPx).	1
1597	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by @PROTEIN$ (GST) and glutathione peroxidases (GPx).	1
1598	We have also described LD between @PROTEIN$ alleles and HLA class II DRB1 allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0
1599	We have also described LD between HLA-G alleles and HLA class II @PROTEIN$ allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0
1600	Vernakalant was metabolized rapidly via 4-O-demethylation by @PROTEIN$ (CYP)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
1601	Vernakalant was metabolized rapidly via 4-O-demethylation by cytochrome P450 (@PROTEIN$)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
1602	To examine the relationship of functional expression of @PROTEIN$ to prognosis in AML, we studied marrow samples from 175 adult AML patients who underwent induction chemotherapy with anthracycline and @COMPOUND$ on Southwest Oncology Group trials.	0
1603	The capacity for osmotic adjustment, superoxide dismutase (@PROTEIN$) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
1604	The capacity for osmotic adjustment, superoxide dismutase (SOD) and ascorbate peroxidase (@PROTEIN$) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
1605	The capacity for osmotic adjustment, @PROTEIN$ (SOD) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
1606	Curcuminoids inhibited @PROTEIN$ in the in-vitro assay with IC(50) value of 19.67, @COMPOUND$ 16.84, demethoxycurcumin 33.14 and curcumin 67.69 microM.	1
1607	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to alkaline phosphatase (@PROTEIN$) which was in turn conjugated to 2,4-D molecule.	1
1608	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to @PROTEIN$ (ALP) which was in turn conjugated to 2,4-D molecule.	1
1609	The SoxN protein is proposed to harbor the heme b of lower reduction potential and the @COMPOUND$ (s), and @PROTEIN$ the other heme b.	0
1610	Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (@PROTEIN$) and rat liver microsomes in the presence of @COMPOUND$.	1
1611	In vivo @PROTEIN$ blockade by @COMPOUND$ significantly increased infarct volumes at 24 h in mice undergoing 30 min of transient middle cerebral artery occlusion (tMCAO).	1
1612	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to thioredoxin (@PROTEIN$), via the cofactor FAD.	1
1613	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to @PROTEIN$ (Trx), via the cofactor FAD.	1
1614	@PROTEIN$ (HIF-1alpha) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
1615	Hypoxia-inducible factor-1alpha (@PROTEIN$) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
1616	Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood @COMPOUND$, @PROTEIN$, CK and CK-MB levels.	0
1617	Molecular and biochemical characterization of a distinct @PROTEIN$ involved in @COMPOUND$ production from Aeromonas media.	1
1618	TyrA had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other @PROTEIN$.	0
1619	TyrA had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other @PROTEIN$.	0
1620	@PROTEIN$ had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other tyrosinases.	0
1621	TyrA had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other @PROTEIN$.	0
1622	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other tyrosinases.	1
1623	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other tyrosinases.	1
1624	EDTA or glutathione notably inhibited the enzymatic activities of @PROTEIN$, whereas @COMPOUND$ and SDS activated them.	1
1625	These results suggest that @PROTEIN$ is the first reported distinct tyrosinase involved in @COMPOUND$ production in the genus Aeromonas.	1
1626	These results suggest that TyrA is the first reported distinct @PROTEIN$ involved in @COMPOUND$ production in the genus Aeromonas.	1
1627	@PROTEIN$ from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental @COMPOUND$ level.	1
1628	Both sodium and potassium ions activated goldfish @PROTEIN$ at low concentrations, with maximal activation at about 80 mM of each @COMPOUND$ salt, whereas higher concentrations became inhibitory.	0
1629	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did phosphate and @COMPOUND$ ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
1630	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did @COMPOUND$ and fluoride ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
1631	Unfolding and inactivation of abalone (Haliotis diversicolor) @PROTEIN$ during denaturation by @COMPOUND$.	1
1632	Unfolding and inactivation of @PROTEIN$ from abalone (Haliotis diversicolor) during denaturation by @COMPOUND$ (GuHCl) of different concentrations has first been studied.	1
1633	We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester), in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, tumor necrosis factor-alpha (@PROTEIN$), and @COMPOUND$ (NO).	0
1634	We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester), in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, @PROTEIN$-alpha (TNF-alpha), and @COMPOUND$ (NO).	0
1635	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as @PROTEIN$, nitrite/nitrate, glutathione peroxidase and @COMPOUND$ were performed.	0
1636	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as superoxide dismutase, nitrite/nitrate, @PROTEIN$ and @COMPOUND$ were performed.	0
1637	The levels of @COMPOUND$ and @PROTEIN$ were lower in ginkgo groups but not significantly.	0
1638	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, @PROTEIN$ and oxytocin transcripts was reduced.	1
1639	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of @PROTEIN$, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
1640	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, @PROTEIN$, CYP19A1 and oxytocin transcripts was reduced.	1
1641	In granulosa-lutein cells, STAR transcript abundance was not affected by @PROTEIN$, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
1642	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and @PROTEIN$ transcripts was reduced.	1
1643	In both cell types, follistatin attenuated the suppressive effect of activin A and @PROTEIN$ on @COMPOUND$-induced P4 secretion but had no effect alone.	1
1644	ETEC infection also caused a drastic inhibition of host @PROTEIN$ activity, as measured by @COMPOUND$ fluorescence.	0
1645	@COMPOUND$ is a nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (@PROTEIN$) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.	1
1646	Mutations known to confer resistance to @COMPOUND$ (@PROTEIN$ C316Y) and boceprevir (NS3 V170A) were present in the combination-resistant replicons.	1
1647	Mutations known to confer resistance to @COMPOUND$ (NS5B C316Y) and boceprevir (@PROTEIN$ V170A) were present in the combination-resistant replicons.	0
1648	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
1649	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
1650	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
1651	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
1652	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to c-Src-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor @PROTEIN$.	1
1653	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to @PROTEIN$-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor AP-2.	1
1654	However, these events were blocked by treatment with the antioxidant, @COMPOUND$ (NAC), as well as @PROTEIN$ overexpression.	0
1655	It decreased TG levels in tyloxapol-induced hyperlipidemia and increased @PROTEIN$ @COMPOUND$ (HDL-C) and reduced atherogenic index in normotensive rats.	1
1656	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
1657	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
1658	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
1659	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
1660	The electrons released from @COMPOUND$ by @PROTEIN$ were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	1
1661	Effects of dissolved @COMPOUND$ tension and agitation rate on the production of heat-shock protein @PROTEIN$ 96 by MethA tumor cell suspension culture in stirred-tank bioreactors.	0
1662	Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by @PROTEIN$ inhibition or @COMPOUND$ chemotherapy.	0
1663	@COMPOUND$ binding to human @PROTEIN$ : a study of protein conformation and binding affinity.	1
1664	This review will focus on recent evidence that @COMPOUND$, @PROTEIN$ and neuropeptide Y act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
